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Introduction 
 
''You can't hold back scientific progress… You can't put it back in the drawer,”1 
—Dr. Etienne-Emile Baulieu (1989) 
 The development of medication abortion (MA) in the 1980s was the first advance to 
significantly affect how abortion care is provided and received since the vacuum aspiration 
method was introduced in the 1950s. It uses two types of pills to terminate a pregnancy, starting 
with mifepristone and followed by misoprostol at least 24 hours later. Prior to that breakthrough, 
nearly all abortion techniques available to medicine had been known since antiquity.2 How is it 
that for a practice as old and routine as abortion, medical innovation has been so incredibly slow 
to advance? The issue lies not with researchers, who depend on funding from sources willing to 
be associated with abortion, but is instead wrapped up in the political, moral and ethical debates 
surrounding the issue. Since the day it was discovered that mifepristone (RU-486) could be used 
to end early pregnancy, its fate has been governed by politics rather than science. 
In France, where mifepristone was first synthesized by Dr. Etienne-Emile Baulieu and 
colleagues in 1980 and approved for use in 1988, anti-abortion groups initially succeeded in 
pressuring the drug’s manufacturer, Roussel Uclauf, to take it off the market. “Side effects were 
in no way a problem,” said Arlette Geslin, director of medical relations for Roussel, “The 
problem was that there were protests, letters threatening to boycott, and demonstrations in front 
of our headquarters. We didn't want to get into a big moral debate.”3 On the same day the 
company withdrew mifepristone, nearly 10,000 physicians and researchers were gathered in Rio 
de Janeiro for the World Congress of Gynecology and Obstetrics, where a protest campaign 
began to rescue the drug.4 As pressure built from physicians, scientists, feminists, and family 
planning organizations, the French government decided to intervene. Minister of Health Claude 
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Evin ordered Roussel to resume distribution of what he declared the “moral property of women, 
not just the property of the drug company.”5 By 1990, MA accounted for some 25-30% of all 
abortions performed in France, 6 results from over 500 published research reports supported its 
use as a safe and effective alternative to surgical abortion, and public health experts recognized 
its potential to drastically reduce abortion-related morbidity and mortality in the developing 
world. 7 
Meanwhile, the US National Institutes of Health (NIH) continued to deny funding to any 
research project involving mifepristone; in 1986, the Secretary of Health and Human Services 
explained this was due to “congressional directives” and “administration policy.8 The only 
privately funded, large-scale clinical trial was cut short due to difficulties obtaining the drug for 
research9. As Gary Hodgen, a scientist in the field, explained in 1990:  
“The problem is not due to any lack of effort by researchers or their professional 
associations. What we are facing is a political agenda of the anti-abortion side that 
acts to directly prevent federal funding and regulatory review of the potentially 
therapeutic effects of RU 486 and similar medications… these political forces are 
the same ones that have blocked federal research funds since the mid-1970s for 
study of human fertilization, embryogenesis, and fetal development. Has this 
limiting of federal leadership and cooperation in reproductive research 
compromised our nation's scientific integrity? Unquestionably, yes!”10 
 
The federal government’s alignment with the anti-abortion movement has compromised not only 
the country’s scientific integrity but also the medical legitimacy of regulations governing access 
to abortion. Despite mounting evidence in support of MA, it would not be offered through the 
formal health care system for another ten years. The tide turned in 1993, when President Clinton 
directed the Food and Drug Administration (FDA) to revoke its import ban on mifepristone and 
initiate its testing, licensing and manufacturing. Soon after, Roussel Uclauf transferred patent 
rights to The Population Council, and data from the clinical trials that followed was submitted to 
the FDA in 1996.11 When the FDA finally did approve the regimen in 2000, the agency attached 
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a set of heavy regulations that make the medication difficult to access and inconvenient to 
prescribe. These regulations are supposedly in place to protect the health and safety of womena 
but are widely recognized as medically unnecessary, and the movement demanding their removal 
is supported by professional organizations such as the American College of Obstetricians and 
Gynecologists (ACOG).12 As a result of the restrictions, MA is sorely underutilized as a way to 
better serve populations in areas with critical abortion provider shortages.  
This incongruity between the stated purpose of abortion regulations and their actual 
effects is nothing new, and it is not unique to the specific method of MA. Federal and state laws 
have unjustifiably limited access to abortion care since the medical profession was established in 
the US. Rather than driving the decline in abortion rates over time, as their anti-abortion 
proponents would like to believe, these laws merely impose hardships on those seeking and 
providing abortion.13 Consequently, women have had to find alternative sources of abortion care. 
Many have heard of the “coat-hanger” or other “back-alley” methods practiced in the era 
before Roe v. Wade legalized abortion in 1973. Some of these services were offered by medical 
professionals who risked the loss of their licenses, while others were done by women themselves, 
such as members of the Jane collective who arranged and performed over 11,000 abortions 
between 1969-1973.14 Yet other women worked alone, trying various home remedies in complete 
secrecy. The risks of illegal abortion varied with the exact technique and skill level of the 
provider, but the overall morbidity and mortality rates associated with the pre-Roe illegal 
underground are harrowing. However, the tragic toll of unsafe abortion cannot be isolated to any 
                                               
a I do not mean to imply that all pregnant people and all who seek abortion care are cisgender women. Trans men 
and non-binary folk are part of this conversation as well, and gender-neutral language about pregnancy would 
instead reference “pregnant people.” Throughout this thesis, my use of the word “woman” reflects the literature and 
science research that centers the term. More research is needed on the experiences of trans and non-binary folk in 
medicine, particularly pertaining to abortion. 
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particular geographic setting nor period of time—still today, it is one of the leading causes of 
maternal mortality worldwide (13%).15 The reality is, there have always been and will always be 
people who would rather face extreme danger—including the threat of death—than continue life 
with an unwanted pregnancy. As access in the US dwindles by day and the possibility of Roe v. 
Wade being overturned looms ahead, Americans are anxiously wondering if past will be 
prologue. In a post-Roe world, how many more lives will be lost to illegal abortion? 
Owing to the advent of MA, the answer could be next to none. Though the only legal 
route to access is over the barriers and through the formal health care system, the pills can be 
found on numerous online pharmacies that circumvent FDA regulations. A woman who places 
an order today could expect to receive the package within three weeks and have successfully 
terminated her pregnancy two days after its arrival. 16  Unlike dilation and evacuation (D&E) and 
vacuum aspiration abortion, the other two methods recommended by the World Health 
Organization (WHO), MA is remarkably simple to administer. It has a consistently proven 
success rate of over 95% through the 12th week of pregnancy, 17 and evidence shows that women 
who can obtain the medications and follow instructions for proper administration can safely and 
effectively provide their own abortions.18 It is worth mentioning that all MA is to a degree “self-
managed,” as women must always manage the symptoms at home (after a doctor hands over the 
medications), but the term only truly applies when the pills have been sourced outside the formal 
health care system. Women who choose to do this shoulder some risk of criminal prosecution, 
but their health and well-being are not otherwise on the line. Although it is impossible to know 
just how populated the route is, research indicates that many are already practicing self-managed 
MA, and interest is growing quickly. 
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Importantly, diminished access to abortion is not the sole force driving demand; a variety 
of factors unique to self-managed MA make it the first choice for some. Not only is it much less 
expensive than clinic-based care on average,19 but the ability to complete the procedure from 
home increases the potential for privacy, comfort and convenience, and some cite autonomy 
during the process and the feeling of empowerment as motivations for seeking abortion pills 
online.20 Women throughout history have elected to self-manage their abortions for many of the 
same reasons, but before MA existed, the most effective methods were also the most dangerous.  
The development of MA has forced us to reevaluate long-established relationships 
between the words “self-managed,” “safe” and “legal.” No longer does safe equal legal, and no 
longer must illegal mean unsafe. For the first time in history, illegal avenues are sometimes the 
most accessible routes to safe abortion, the primary risks of self-managed abortion are legal 
rather than health-related, and some people may choose to self-manage out of preference rather 
than necessity.  
This thesis is by no means a comprehensive account of self-managed MA. When I refer 
to “MA,” I am specifically speaking of the combined use of mifepristone and misoprostol. By 
focusing on this dual-drug regimen, I am abbreviating an equally worthwhile discussion of the 
“miso-only" method. Misoprostol can be used alone, in three separate rounds administered 3-12 
hours apart, at an 85% success rate. Though this protocol is less effective than the combined 
regimen, it can also be used safely through the 12th week of pregnancy and is recommended by 
the WHO when mifepristone cannot be obtained. 21 Misoprostol is much less expensive and far 
more accessible than mifepristone, as it is commonly used to treat ulcers and arthritis and can be 
found over-the-counter (OTC) in many countries, including Mexico. I follow the lead of most 
research conducted in the US in choosing to focus on the dual-drug regimen; the fact that it is an 
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FDA-approved, standard treatment has enabled the collection of far more data. For similar 
reasons, when I mention “self-managed MA,” I am generally referring to the practice of self-
sourcing the pills through online, unregulated pharmacies. Although this is far from the only 
channel used to obtain them, we know much less about the alternatives, and hardly any data on 
them exists. 
In this thesis, I explore how the politicized history of abortion in the US has influenced 
the emergence of MA and manipulated the ways in which it is used and understood, considering 
its potential as a tool for harm reduction, health equity and social change. Even when not 
explicit, this inquiry constantly draws on the theories of Actor-Network Theory (ANT) and 
reproductive justice. The former is an approach to social theory that hinges on networks of 
human and non-human actors surrounding all technological achievements, each entity acting 
according to particular interests.22 It is a useful tool for conceptualizing the power and 
motivations of entities such as state legislatures, regulatory bodies, abortion providers and those 
seeking care, as well as for characterizing the relationships among them. “Reproductive justice,” 
is a framework that centers material access to abortion rather than the theoretical ability to 
“choose.” It is “the human right to maintain personal bodily autonomy, have children, not have 
children, and parent the children we have in safe and sustainable communities.”23 The framework 
aims to deconstruct power systems and center those most marginalized, making it an ideal lens 
through which to consider the benefits of MA. Ultimately, I argue that MA has been 
underutilized as an instrument of reproductive justice due to longstanding and unbalanced power 
dynamics in the struggle for reproductive control—power dynamics that are threatened and 
destabilized by the practice of self-managed MA. 
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My first chapter provides a brief history of self-managed abortion with the goal of 
highlighting how MA revolutionized the practice. Whereas we typically think of abortion as a 
medical procedure, it was, until relatively recently, a skill learned from hands-on experience. 
Early knowledge about abortion came from observing miscarriage, and boundaries between the 
two were blurry. Rather than seek care from a doctor, women were more likely to turn to friends 
or midwives for counsel, and traditional remedies were typically applied at home. Notably, we 
see that preferences such as privacy have long contributed to women’s decisions about abortion, 
and that for millennia, the practice was largely self-managed. Before mifepristone and 
misoprostol were available, self-managed abortion necessarily carried a low chance of success 
and high risk of complications. This is still true in some parts of the world, though abortion 
medications are gradually succeeding traditional methods. They are overwhelmingly safe when 
used as recommended by the WHO but can still be dangerous when taken in improper doses or 
too far along in pregnancy.  
In Chapter Two, I chronicle the development of MA and review the science at play. We 
see how the push to put mifepristone on the market in France exacerbated tension between anti-
abortion groups and feminist activists as well as invited controversy over potential adverse health 
effects. As the science became more clear, public perception did not; the debate remained highly 
polarized despite an increasing number of studies validating the safety and efficacy of MA. In 
this chapter, I draw special attention to the similarities between MA and miscarriage, the natural 
result of 15-20% of all pregnancies.24 Not only are their mechanisms nearly indistinguishable, 
but so too are their symptoms, complication rates and follow-up treatment. A brief overview of 
the legitimate health risks associated with MA is included to emphasize the contrast between 
current regulations and what is medically justifiable.   
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This prompts Chapter Three’s inquiry of how and why such scientifically unsound 
regulations came to be. By tracing back their roots in the struggle for reproductive control, 
persistent patterns of race- and class-based inequality materialize. That is, low-income women 
and women of color have borne the brunt of hardships imposed by abortion restrictions and 
experienced adverse health effects at higher rates than their white, middle-class and wealthy 
counterparts. Their reproductive autonomy, along with that of people with mental and 
intellectual disabilities, has also been disproportionately suppressed by abuses such as 
sterilizations forced by racist, eugenic actors. As explained by Loretta Ross, a cocreator of the 
reproductive justice framework, “past abuses of women’s reproductive bodies live on in 
contemporary harms and coercion.”25 Various entities throughout history have repressed and 
exploited the reproductive capacity of the most vulnerable populations. As the analysis will 
show, the mechanisms have changed over time, but the reasons are rooted in the same 
unbalanced power dynamics.  
In Chapter Four, I illustrate how these dynamics would likely materialize in a new phase 
of the struggle for reproductive control, one in which Roe has been overturned or rendered 
ineffective. We see that once again, marginalized communities would feel the consequences 
disproportionately, while abortion would remain accessible to those who can afford to travel for 
services. In fact, this picture isn’t that different from our current reality. Self-managed MA is 
often billed as the starring role in a post-Roe world, but it’s already the most accessible path to 
safe abortion for many who live in abortion deserts today. Demand for unofficial sources of 
abortion pills is certainly increasing, but among a much wider population than would be 
expected if barriers to access alone were driving demand. In this chapter, I argue that we must 
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look beyond the context of a post-Roe world in order to fully understand the potential uses and 
subversive power of self-managed MA. 
Whether this subversive power is any match for the institutionalized power of state and 
medical control is the subject of Chapter Five’s investigation. Drawing on the ANT approach, I 
inspect the functions and motivations of various actors with a stake in how abortion pills are used 
and distributed. These relationships call into question the legitimacy of authoritative power 
claimed by the government and its regulatory bodies. I make the case that MA regulations, which 
serve no medical purpose, are manifestations of the politicization of abortion that rely on 
increasingly unsteady power dynamics among women, physicians, activist networks, lawmakers, 
online unregulated pharmacies and the FDA. Furthermore, I argue that the American federal 
government’s authority is seriously threatened by international actors that ship abortion pills to 
US residents and provide all the information needed to successfully manage their own abortion. 
Though it is unclear how this power struggle will resolve, it certainly has the potential to shift 
deep-rooted dynamics.  
In my concluding chapter, I connect the power-shifting abilities of MA to its expansive 
potential as a tool for achieving reproductive justice. In the words of Marlene G. Fried and Susan 
Yanow, the two women who introduced “self-managed abortion” into my vocabulary at the 2019 
Civil Liberties and Public Policy Conference (CLPP): “Looking at self-managed abortion 
through a reproductive justice lens highlights the ways in which the practice lies at the 
intersection of human rights, public health, empowerment and access.”26  
I must acknowledge that I cannot and do not present a narrative of self-managed MA that 
is representative of the diverse range of experiences it generates. In an attempt to balance the 
narrative as best I can, I draw from a wide variety of sources and incorporate first-hand accounts 
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where possible. Nonetheless, my positionality as a white, cisgender and middle-class woman 
means I am particularly ill-equipped to imagine, interpret and analyze perspectives from the 
marginalized communities centered in a reproductive justice framework. As a result, there will 
be important pieces left unsaid and unanalyzed; I apologize in advance for these omissions and 
welcome both critique and continued conversation. 
I would be remiss not to also recognize the rapidly-evolving nature of this subject 
and its impact on my work. I began my research in the midst of an unprecedented wave 
of extreme anti-abortion legislationb that succeeded in bringing the first major abortion 
case to the US Supreme Court since Brett Kavanaugh’s confirmation in 2018. That case, 
June Medical Services v. Russo, was argued on March 4th, and the decision is expected 
later this year,27 as the onslaught of radical legislation continues and we gear up for a 
fateful election season. Much is at stake in 2020, and those aware of self-managed MA’s 
key role in a post-Roe America have been working overtime to spread information and 
build grassroots support. I knew my research would be complicated by a surge of stories 
with titles along the lines of: “More People Are Starting to Prefer Doing Their Abortions 
on Their Own,”28 One thing I did not anticipate, however, was a global pandemic that 
would further obstruct access, disrupt the international supply chain of abortion pills and 
bring MA regulation into the national spotlight. 
The Coronavirus Disease 2019 (COVID-19) emergency has necessitated the 
suspension of “nonessential” medical procedures and compelled the broad shift to 
telemedicine.29 To prevent unnecessary travel, interaction and use of limited medical 
                                               
b According to the Guttmacher Institute’s “State Policy Trends 2019,” of the 58 restrictions passed in 2019, 25 
would ban all, some or most abortions at the state level. In violating Roe v. Wade, these laws are designed create 
opportunities for the US Supreme Court to undermine its constitutional protections. 
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resources, the UK government temporarily changed abortion policy to allow delivery and 
at-home use of abortion pills.30 In the US, several senators and a coalition of 21 attorneys 
general have urged the federal government to do the same:  
“People who need an abortion cannot delay care and should not needlessly risk 
coronavirus exposure. Given the years of scientific evidence indicating that 
medication abortion is a safe and effective treatment, we ask that FDA take 
immediate steps to temporarily exercise enforcement discretion on in-person 
dispensing requirements, so that people can more easily access abortion care 
without putting themselves or their health care providers at risk of infection from 
COVID-19,”31 - Senators Elizabeth Warren (MA), Patty Murray (WA) and 
Tammy Baldwin (WI) 
 
“The FDA should not mandate this medically unnecessary travel, particularly 
during the COVID-19 crisis where not only are women being advised to stay 
home, but families are faced with additional childcare and financial 
constraints,"32—attorneys general from 21 states  
 
Meanwhile, the US is seeing a wave of anti-abortion opportunism. As of April 14th, 2020, 
politicians in thirteen states had attempted to use the pandemic as an excuse to ban 
abortion altogether by falsely labeling the procedure as “nonessential.”33 This is merely 
the latest example of such actors prioritizing political interest over the goal of public 
health. In another thesis, one I embarked on today, my core chapters would explore the 
effects of COVID-19 on patterns of perception and utilization of MA. Though the past 
year has brought much more change than I will be able to address, this thesis reflects my 
understanding of the situation as of April 15, 2020. Going forward, I suspect this will be 
an interesting moment in the history of self-managed MA upon which to reflect as its 
evolution continues. 
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Chapter One  
A History of Self-Managed Abortion 
 
“Over the centuries there developed a varied technology of abortion—magical and mechanical, 
external and internal. When abortions became illegal, these techniques merely went 
underground. In fact, there is striking continuity between abortion techniques used in ancient 
societies and those used in modern ‘home-remedy’ abortions,”34 
 —Linda Gordon, The Moral Property of Women 
Self-managed abortion, also called self-induced, self-sourced, self-administered, or 
“DIY” abortion, describes any action taken by a person to intentionally end their own pregnancy 
without the supervision of a clinician. Although this thesis focuses on one method in particular 
(the combined use of mifepristone and misoprostol in the MA regimen) it is important to frame 
its development as the latest chapter in a long history—one which is often misconstrued in 
debates of high morals and principles. In reality, abortion is and has always been a matter of 
compelling circumstances; in almost every society to date, there have been women who feared 
continuing an unwanted pregnancy more than the risks associated with ending it. Today, the 
most likely consequence of inducing an abortion with modern medication is legal punishment, 
but for centuries self-managed abortion was often fatal. Until misoprostol and mifepristone came 
into use as abortifacients, the most effective DIY methods were those that posed the greatest 
threat of death. To understand how the advent of MA revolutionized the practice of self-managed 
abortion, we must place it in the appropriate historical context. 
In the Ancient World 
Home remedies for early-term abortions are described in many ancient texts. The earliest 
known Egyptian medical document describes using plant substances, and a 4600-year-old 
document from China advocates the use of the highly toxic chemical mercury.35 Texts from 
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classical antiquity also confirm that abortion, though frowned upon by some, was generally 
considered a standard practice. Most Greek doctors were willing to perform abortions for 
medical reasons, and few would refuse to treat a woman seeking help after attempting to self-
induce and harming herself. 36 Still, women were more likely to seek the counsel of a midwife, 
medical woman, or friend who was knowledgeable about pregnancy, as all knowledge of 
induced abortions came from experience with miscarriage. That is, the same situations and 
substances used to safeguard pregnancy could also be used as abortifacients: 
“After the conception one must refrain from any exaggeration and agitation, 
physical and mental, for the sperm is expelled as a result of sudden fear and 
sorrow and joy, and on the whole as a result of a powerful shock of the mind, and 
strenuous exercise and violent intermissions of breath, coughs, sneezes, beatings, 
falls—and in particular on one’s back—lifting weights, jumps, hard seats, use of 
drugs, administration of pungent drugs and sternutatories, malnutrition, 
indigestion, drunkenness, vomiting, looseness of the bowels, loss of blood 
through the nose, the hemorrhoids or another outlet, relaxation through an agent 
which can increase the temperature, and because of high fever, and shiver and 
spasm, and in general anything which can cause a violent motion, that is, the 
means to cause an abortion,”—Soranus, 2nd century AD.37 
 
Because perceptions were influenced by religion and superstition, and abortion was linked to 
irrelevant factors such as shock, sorrow and sneezing, available knowledge on the matter was not 
very accurate. Even so, this did not bear much impact on the actual practices and procedures, as 
induced abortion was a skill people learned from hands-on experience.  
Information from medical and non-medical texts suggest that by the classical period, a 
huge variety of methods were already known and practiced. Oral drugs were both the most 
accessible and the least troublesome, ranging from simple substances such as cyclamen plants to 
complex potions made of several ingredients in precise measurements. Modern science has 
shown that some herbs, such as cyclamen, mountain rue, birthwort, bryony and squirting 
cucumber actually do possess the abortifacient properties attributed to them, but the toxicity that 
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served to terminate a pregnancy could also be detrimental to the mother. 38 As Galen summarizes: 
“Most of the drugs… are too weak to be efficient from such an undertaking, but some, even 
though potent, are dangerous for human life.” 39  
Similar substances were sometimes applied as vaginal suppositories, which carried 
greater risks overall. These suppositories were explicitly prohibited in the Hippocratic Oath 
(which did not ban abortion altogether), likely because their irritant properties often caused 
ulcerations, inflammation and septic abortions.40 A woman weary of medical risk might first try 
oral drugs, or, for an even lower chance of harm (and success), she might externally apply an 
abortifacient cream to her abdomen. If these methods failed, or if access to abortifacients was an 
issue, she could attempt to induce an abortion by means of physical violence or over-exertion. 
Although mechanical means offered the advantage of being able to present the abortion as an 
accident, its already limited efficacy was completely dependent on the woman’s courage and 
ability to exert substantial violence onto her own body.41 
The lack of relevant writing by women makes it difficult to determine just how much 
they knew about these methods and their associated risks. It is nevertheless clear that abortion 
was understood to be a dangerous endeavor, as confirmed by references in non-medical 
literature. The Roman poet Ovid provides an example in the 13th piece of his second book: 
Aiming to end her pregnancy—so rashly— 
Corrina lies exhausted, life in doubt. 
To run such fearful risks without my knowledge 
Should make me rage, but fear’s put rage to rout… 
O Isis, patroness of Paratonium… 
Turn your eyes here; on her—and me—have mercy; 
You will give life to her and she to me.. 
You too, kind Ilithyia, who take pity 
When girls are locked in labour, and relieve 
Their hidden load, be present, hear my prayer…   
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Because women who wanted to terminate usually wanted to hide the existence of the pregnancy 
in the first place, they were unlikely to seek help from well-known and experienced practitioners. 
Some turned to friends, midwives, religious figures, magicians and others with obscure 
credentials for advice or assistance, while others self-managed completely.42 Thus, methods that 
could be used in the privacy of one’s own home, such as drugs administered orally or externally, 
pessaries and mechanical means, were highly attractive for their guaranteed secrecy. Women 
often combined techniques, starting with safer and less painful options and moving on to more 
drastic measures. Just how far she went would depend on the availability of abortifacients, the 
urgency of her circumstances and her state of mind. As an absolute last resort or in an 
emergency, she might go to a practitioner for surgical abortion, but poor sterilization techniques 
and the lack of anesthesia and antibiotics made each procedure an excruciating, life-threatening 
ordeal.43 
  Abortion in the ancient world was largely self-managed. Women typically induced their 
abortions alone or with the guidance of non-doctors, and from the wide variety of documented 
methods, it is clear that they were willing to go to great lengths and experiment with highly toxic 
substances in order to end unwanted pregnancies. Not even the threat of death could deter a 
woman if she believed that continuing the pregnancy under existing circumstances would make 
life unbearable. Evidence suggests that the phenomenon has existed in almost every society to 
date, making self-managed abortion an extremely old practice that is unlikely to ever disappear.   
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In the Modern World 
 
 
Figure 1. Coded advertisement for abortion services in an 1865 newspaper, annotated by Thompson. 
Source: Lauren MacIvor Thompson, The New York Times, 2019 
Figure 2. Coded advertisement for abortifacients in an 1894 newspaper, annotated by Thompson. 
Source: Lauren MacIvor Thompson, The New York Times, 2019 
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In 19th century America, what was considered “birth control” included breastfeeding, 
abstinence, the rhythm method, vaginal douching and the use of herbs thought to stimulate 
menstruation. Though these practices were often dangerous and largely irregulated, women 
considered them essential, as evidenced by the prevalence of newspaper advertisements that 
promoted abortifacients in coded language by the 1820s (Figures 1-2).44 Some of these 
substances, such as pennyroyal, were among the herbs recorded in early history, which have 
been used in many societies since. Around the world, however, self-managed abortion methods 
developed with as much variation as any other cultural practice. In several African countries, 
traditional herbs were supplanted by laundry bleach; in Britain, they were replaced by gin, iron 
filings and quinine. Women in late 20th century Morocco reported using herbal potions, 
contraceptive pill cocktails and squatting over a dish of smoking herbs to induce bleeding, while 
women in Thailand regularly practiced traditional abdominal massage. Despite the high risk of 
hemorrhage and pelvic inflammation, these procedures outnumbered abortions by Thai 
physicians 2500 to one at the turn of the 21st century.45 Meanwhile, women in Brazil had 
discovered that the over-the-counter drug Cytotec (misoprostol), introduced there in 1986 for the 
treatment of gastric ulcers, could be adapted as an abortifacient.  
Misoprostol has since been approved in many countries for medical termination of 
pregnancy, and in those where it is only available for gastric-related indications, “off-label” use 
is growing for self-managed abortion.46 Used alone, it has a success rate of 75-80% through the 
12th week of pregnancy and offers a safe alternative to the combined misoprostol-mifepristone 
regimen, which is 95-98% effective in completing early abortion.47 WHO recommends both 
methods but prefers the dual-drug regimen when mifepristone is available.48 According to The 
Medical Abortion Commodities Database, mifepristone is licensed for use as an abortifacient in 
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46 countries, and misoprostol is available for one or more indicationsc in 99 countries.49 When 
MA care is provided by a practitioner, the abortion is not “self-managed,” even though much of 
the process, including the actual passing of the pregnancy, happens outside of the clinic. The 
procedure is considered self-managed when carried out without the supervision of a clinician, 
which entails obtaining the medications through unofficial channels. Though online pharmacies 
are the focus of most research and media coverage, there are other ways to self-source the pills, 
such as buying from individual sellers. 
The risks of self-managed abortion vary alongside the methods. Of those that have been 
discussed, modern abortion medications are the only safe options. Although the quality of 
evidence is greatest for pregnancies in the first trimester, a growing body of literature suggests 
that both the combined MA regimen and misoprostol alone can be used safely and effectively far 
past that window.50 For each method, WHO has different guidelines for dosage, timing and route 
of administration depending on the gestational age, while the FDA only approves a specific dual-
drug regimen up to 10 weeks’ gestation.51 
The demonstrated safety of self-managed MA prompted the WHO to reconceptualize its 
longstanding dichotomy between “safe” and “unsafe” abortion. The organization defines unsafe 
abortion as “a procedure for terminating a pregnancy performed by persons lacking the necessary 
skills or in an environment not in conformity with minimal medical standards, or both,” and for 
an abortion to be “safe,” it must be provided by a health-care worker.52 In this framework, a self-
managed abortion cannot truly be classified as safe even when WHO guidelines are followed. 
Yet, WHO also recognizes that broader use of abortion pills has been linked to decreased 
                                               
c In addition to prevention and treatment of gastric ulcers and medical termination of pregnancy, misoprostol can be 
used for various obstetric indications including ripening of the cervix, induction of labor, prevention and treatment 
of post-partum hemorrhage and treatment of incomplete abortion. 
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complications from unsafe abortion.53 This contradiction compelled WHO to redefine safety as 
existing on a continuum of risk, one that considers social and legal context in addition to 
technique and physical setting.54 Similarly, experts at the Guttmacher Institute describe moving 
toward a “spectrum of safety” that recognizes three main categories: safe, less safe, and least 
safe.55 In order for an abortion to be less safe, it must meet one of WHO’s two criteria for a safe 
abortion—(1) the provider must either use a WHO-recommended method or (2) have the 
appropriate training. Safe abortions meet both criteria, and least safe abortions meet neither. In 
this system, properly administered MAs are considered less safe, and all other “DIY” methods 
are least safe. 
There are some cases in which MA, too, would be considered “least safe,” such as when 
a woman takes the incorrect dosage or obtains counterfeit drugs. This usually happens when the 
pills are bought from individual sellers found through personal networks. A recent study 
conducted in Chile revealed this to be common experience there.56 As a woman named Karina 
told the researchers: 
“My best friend had an abortion, and she was the first person I went to. I knew 
she would help; she had the information, which she had from a feminist group in 
my Faculty. She gave me the telephone number and put me in contact with a 
person who I phoned and bought the pills from.” 57  
 
There is no standard among these pill sellers, and they offered different types and numbers of 
pills with various price tags. Another woman, Wilma, described her interaction with the seller: 
“He said: ‘I have 2 types of pills. One that costs $70,000 for 4 misotrol, and one 
that costs $90,000 which includes 6 mifepristone, which I think is the best dose to 
use. It's up to you.’” 58  
 
Even though half of the participants consulted online activist networks for instructions, and a 
third asked medical professionals for advice, many did not get accurate information on dosage 
and administration. Of the 30 women, 27 sought medical attention at some point during the 
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abortion process and nine required further treatment—a 70% success rate.59 It is clearly in the 
interest of public health to spread accurate information about how to properly take abortion 
medications.  
The use of mifepristone and misoprostol is increasing globally, but at greater rates in 
industrialized countries where barriers to access are lower and fewer. In developing countries, 
pill sources are generally less reliable, and barriers push many down more dangerous routes. As 
a result, almost all abortion-related deaths occur in those countries, accounting for 4.7-13.2% of 
all maternal deaths and making unsafe abortion one of the leading causes of maternal mortality 
worldwide.60 Other barriers to safe abortion include restrictive laws, poor availability of services, 
high cost, stigma, conscientious objection of health-care providers and unnecessary 
requirements.61 
 Though some difficulties persist when seeking self-managed MA, it has never been 
easier or safer to terminate one’s own pregnancy. So long as one is able to access the internet, 
understand the instructions of unregulated pharmacies and activist networks and receive mail, 
safe abortion is within reach. Cost remains an issue for some—a 2018 study, “Exploring the 
feasibility of obtaining mifepristone and misoprostol from the internet,” found that prices ranged 
from $110 to $36062—but a universally affordable option has existed since March of 2018, when 
Dr. Rebecca Gomperts launched a website called Aid Access. The site connects pregnant people 
with a physician who can remotely determine their eligibility for MA and refer them to a 
pharmacy in India that fulfills the prescription. A $90 donation is suggested, but the service is 
provided on a sliding scale fee. Should the proportion of people seeking care who cannot pay 
increase, Aid Access’s ability to continue shipping pills for free will be put to the test. Additional 
hardships exist for people who don’t have internet access, who face language barriers, who lack 
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mailing addresses or who need to hide their actions from the people they live with, and many 
who need self-managed care may not even know a safe option exists. Though self-managed MA 
by no means eliminates all barriers, for many, it is the most accessible route to safe abortion.  
Before the development of MA, no road to safe abortion could bypass the doctor’s office; 
it takes extensive training and experience to become a competent provider of vacuum aspiration 
and D&E abortion. In contrast, MA workshops train clinicians in a matter of hours,63 and the 
necessity of formal training is debatable. Studies reporting high success rates from at-home 
administration suggest that the ability to follow a simple set of instructions is all one needs to 
safely operate as their own provider. This can of course be complicated by language barriers, and 
it assumes that authentic medications in the proper dosage can be acquired. Still, owing to 
modern medication, the perils of self-managed abortion are no longer necessarily health-related. 
The true magnitude of this achievement can be appreciated only after looking back in 
time and around the world. As Linda Gordon writes in The Moral Property of Women, a book 
lauded as the most complete history of birth control ever written: “Women accepted the pain and 
danger of abortion in the same manner that they accepted the pain and danger of childbirth, with 
the assumption that both were necessary for their own and their communities’ health and 
welfare.”64 Our knowledge of traditional practices, though limited, is evidence that women have 
long sought to control reproduction and viewed birth control as their responsibility. Some went 
to greater lengths than others, and those who needed to disguise their actions often accepted 
additional risks. While safe abortion eventually became standard medical practice, communities 
deprived of professional medical care, whether due to economic or legal constraints, continued to 
depend on “home remedies.” Modern DIY techniques bear many similarities to those used in 
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ancient societies, which explains the costly contribution of unsafe abortion to global maternal 
mortality rates. The difference is, these deaths are now avoidable. 
Unsafe self-managed abortion continues not because safe technology doesn’t exist, but 
because it has been suppressed. The advent of MA created a safe, effective method easily carried 
out in the privacy of one’s own home, and it came with the potential to revolutionize the long, 
varied practice of self-managed abortion. In the following chapter, I will explore the discovery of 
this potential, fraught as it was with controversy, as well as the actual science at play. In doing 
so, I hope to highlight how politics have worked against fact from the very beginning. 
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Chapter Two 
The Development of Medication Abortion 
 
“One persistent theme in this story is that members of the women's health and family planning 
communities, the pharmaceutical industry, or the antiabortion movement have publicly 
questioned the sincerity of the public statements made by each other…As a result, there is no 
single authoritative source of information on the motivations of those who have worked to 
promote or to discourage the development of the so-called abortion pill,”65 
—R. Alta Charo, “A Political History of RU-486”  
The dual-drug MA regimen was not possible until mifepristone came onto the scene in 
the early 1980s. It was first synthesized by Georges Teutsch, Daniel Philibert and Etienne-Emile 
Baulieu, scientists affiliated with the pharmaceutical company Roussel Uclauf (hence the 
original trade name RU 486). Since its arrival, some entities have fought to keep MA far out of 
reach while others have urged its broad distribution. This chapter attempts to contextualize the 
development of MA in its fractured reception, which endured despite increasing clarity of the 
associated risks. Both sides claimed to have women’s health and safety at heart, but neither were 
inclined to let the facts speak for themselves. Where did the disconnect between evidence and 
discourse begin, and how has it manifested in current understandings and applications of the 
technology?  
A Polarized Reaction 
The introduction of MA in France coincided with a global wave of anti-abortion 
fundamentalism incited by the US Supreme Court’s landmark ruling in Roe v. Wade. Just one 
month after the Health Ministry of France gave Roussel Uclauf marketing approval in 1988, 
threats from anti-abortion groups pressured the company to withdraw distribution.  Their success 
lasted all of two days, until the French government ordered Roussel Uclauf to resume 
distribution. Since then, all national introductions of mifepristone have been met with resistance 
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from anti-abortion groups. When these efforts came to the US, feminist groups responded with 
literature imploring allies to fight back. This had the effect of polarizing public dialogue on the 
issue from the start. It left little room for feminists to question the safety and efficacy of 
mifepristone, as that would have been perceived as playing into the hands of the “bad guys,” 
enemies who were merely interested in advancing their campaign against a woman’s right to 
abortion.66 
Perhaps hoping to distance themselves from the controversy, Teutsch, Philibert and 
Baulieu denied that their intention was to discover an abortifacient. Instead, they claimed to have 
been searching for a molecule that would bind to the glucocorticoid receptord when they 
accidentally synthesized a steroid that also served as a progesterone antagonist. Because Baulieu 
had an established interest in hormonal contraception, the team carried out further investigation 
that confirmed the drug’s ability to prevent ovulation and interrupt pregnancy. After 17 months 
of trials on animals, mifepristone was deemed safe enough to warrant clinical trials on women—
an unusually fast application of basic research findings that was attributed to competition from 
American and German pharmaceutical companies.67 Early success rates for termination using 
mifepristone alone varied from 54%-90%, demonstrating the need for protocol enhancement. 
The solution came in the form of prostaglandins.68 
 Misoprostol, which had been used to induce uterine contractions and terminate 
pregnancies since 1970, became the prostaglandin of choice for its low cost, long shelf life 
without refrigeration and worldwide availability.69 Abortion success rates were expected to 
increase when a dose was administered following mifepristone. Though initial results were 
disappointing, later studies that varied the administration route of prostaglandin and dosage of 
                                               
d Which is indeed another function of the steroid—discussed on page 18. 
 Matthews 28 
mifepristone proved the combined approach to be more effective than mifepristone alone, 
reducing failure from 20% to 2-4%.70 It is worth noting that these clinical trials were carried out 
before basic research had been done to rule out potential adverse effects from the interaction of 
the two drugs, although later studies found no such effects with the dosages used .71 
Notwithstanding potential shortcuts taken to get mifepristone on the market, its administration in 
conjunction with a prostaglandin analogue has been consistently verified as a safe and effective 
method of interrupting pregnancy.  
 The response from American feminists was very enthusiastic, generating a campaign that 
called on Roussel Uclauf to distribute mifepristone in other countries, including the US. The 
Reproductive Health Technologies Project initiated the campaign, gaining support from the 
Feminist Majority as well as American Medical Association (AMA) and Planned Parenthood.72 
Criticisms have been leveled at the feminist press for being exceedingly optimistic during this 
time—specifically, for promoting mifepristone as a “miracle drug” without noting the possible 
side effects and slight chance of failure. Perhaps they did present an oversimplified version of the 
debate in which the struggle is entirely between “bad” antiabortionists and “good” scientists who 
made the drug to help women reclaim their “moral property.” 73 Since then, however, the 
messaging of activists has evolved to conscientiously promote safe and effective use of MA 
while fighting for increased access.  
 A major shift occurred in 2000, when the FDA approved mifepristone under the brand-
name Mifeprex for early abortion with misoprostol. The regimen consists of one 200mg tablet of 
mifepristone taken orally, followed 24-48 hours later by 800mcg of misoprostol taken buccally 
or sublingually. Even with its legal status, significant barriers to MA access remain, in large part 
due to the FDA’s institution of a Risk Evaluation and Mitigation Strategy (REMS). 
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According to their website, the FDA can require a REMS “for certain medications with serious 
safety concerns to help ensure the benefits of the medication outweigh its risks.”74 In the case of 
Mifeprex, distribution is restricted to registered providers in clinics, hospitals and medical 
offices. Each provider is required to enroll in a national registry, which effectively deters those 
who would be willing to provide MA care if it didn’t make them public identifiable as an 
abortion provider.75 As we will return to later, increasing the distribution of accurate information 
and lifting the REMS have become priorities of activists, who characterize the classification as 
the misuse of a tool meant for drugs with high-risk profiles. In 2016, the FDA’s label was 
changed to better convey the drug’s safety and efficacy and establish modifications to the 
REMS, but these did not affect any material change.76 Activist efforts thus continue to focus on 
abolishing REMS in addition to expanding access, decreasing the cost barrier, reducing social 
stigma and increasing public awareness of proper administration techniques, side effects and 
risks. 
 Increasing access to abortion pills has been an uphill battle, and stigma and fear continue 
to pollute the narrative. A 21st century self-managed abortion is nothing like the “back-alley” 
methods that haunt our conceptions of a “post-Roe” world, yet the coat hanger lives on a symbol 
of illegal abortion. When self-managed MA does come into the conversation, it is frequently 
discussed using the rhetoric of harm reduction, a common-sense approach that aims to minimize 
the adverse consequences of risky behavior (for example, using a nicotine patch would be a 
harm-reduction approach to smoking cigarettes). When applied to self-managed MA, it typically 
frames the practice as a “less unsafe” option to turn to when clinician-supervised abortions are 
inaccessible. This is far from the full picture; beyond creating a universal opportunity for safe 
abortion regardless of the law, the method is preferred by many who value the enhanced privacy, 
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autonomy and convenience that sets it apart from other options. Thus, the rhetoric of harm 
reduction is reductive and should not be the only language used to discuss self-managed MA. It 
is especially imperative to promote a more nuanced narrative of the technology because those 
who favor it have historically rushed development and downplayed disadvantages, while anti-
abortion activists have intentionally contorted the science to serve their goals. One popular and 
intentional tactic of the far right is to conflate abortion pills with emergency contraception (EC), 
as Kanye West did on video in a recent interview.77 However, they’re far from the only people 
who make this mistake, and the public confusion between MA and EC highlights a concerning 
lack of understanding of the science behind these technologies. To understand MA’s mechanism 
of action and how it compares to that of EC, it is necessary to contextualize both in the basic 
science of pregnancy. 
The Science 
Unlike morning-after pills, which help to prevent a pregnancy from occurring, abortion 
pills help end a pregnancy that has already begun. An individual typically learns they are 
pregnant through an at-home pregnancy test that detects the presence of a hormone, human 
chorionic gonadotrophin (hCG), which is released when the embryo attaches to the uterus. The 
moment such a test can detect a pregnancy is the same moment that medical, legal and 
governmental authorities all consider to be its beginning—implantation.78 An embryo may 
complete this process of burrowing deep into the uterine lining anywhere between 6-12 days 
after “conception” (fertilization) which could happen up to 18 days after unprotected intercourse 
or artificial insemination.79  
For pregnancy to occur, fertilization must happen within 12-24 hours of ovulation, when 
an oocyte is released from an ovary into a fallopian tube. After this time, the egg begins to 
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rapidly deteriorate, and fertilization will either fail or lead to a defective embryo. However, 
because spermatozoa can survive in the female reproductive tract for 5-6 days, the “fertile 
window” of the menstrual cycle extends from 5 days before ovulation to the day of ovulation.80 
During this period, unprotected intercourse may result in fertilization, but emergency 
contraception can be used to reduce this risk. Though there is some disagreement among 
scientists, the overwhelming majority of research suggests that EC works by inhibiting ovulation, 
thereby eliminating any chance of fertilization. Both types of EC pills available in the US, 
levonorgestrel-containing (LNG) and ulipristal acetate-containing (UPA), have been proven safe 
and 75-95% effective depending on how soon after intercourse it is initiated.81 This must happen 
within 5 days, during the “fertile window,” as blocking ovulation would have no effect on an 
already-fertilized embryo nor an established pregnancy.   
Even if EC fails, it is far from guaranteed that pregnancy will occur. Exact estimates 
vary, but somewhere between 40-70% of embryos are lost between fertilization and birth, with 
10-40% of losses occurring before implantation.82 About half are due to chromosomal errors 
from mitotic division, and many others result from poor timing. The embryo must begin the 
process of implantation within a specific window when the endometrium lining is receptive to 
adherence, called the window of implantation (WOI), which begins 6 days after the post-
ovulatory progesterone surge and lasts about 2-4 days. 83 Embryos that arrive outside this period 
often fail to implant, and those that succeed are at high-risk of spontaneous abortion later on. 84 
Spontaneous abortion, also referred to as early pregnancy loss or miscarriage, is an extremely 
common phenomenon, and it is physically nearly indistinguishable from MA. To see this, it’s 
important that we have a basic understanding of the role of hormones in pregnancy.    
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Before a successful pregnancy can be established, the reproductive system must prepare 
itself for the possibility. Right after ovulation, progesterone begins the work of thickening the 
uterine lining to make it possible for a fertilized egg to attach. After implantation, the hormone 
has the additional duties of keeping the uterus malleable enough to accommodate growth of the 
embryo, blocking muscle contraction to prevent menstruation and allowing uterine blood vessels 
to surround the embryo. It also stimulates the production of new vessels and starts to form a 
region called the decidua, which eventually becomes the maternal portion of the placenta. In 
turn, the decidua instructs external trophoblast cells of the embryo to form the embryonic portion 
of the placenta. These trophoblast cells are key players in establishing pregnancy, as they lead 
the way in “invading” the uterine tissue after adhering to its lining, after which they begin to 
secrete hCG. Throughout early pregnancy, measurements of hCG are used to assess how the 
pregnancy is progressing, as its primary role is to nourish the embryo by maintaining production 
of progesterone. Unusually low levels may indicate a potential miscarriage, whereas very high 
levels could indicate twins or, in rare cases, trophoblastic disease.85 The concentration of hCG 
peaks between weeks 8-10 and plateaus at a lower level for the rest of pregnancy, at which point 
the placenta takes over the vital role of progesterone production and substantially increases 
output.86 If there’s one thing to remember, it’s that progesterone runs the show. 
When progesterone levels are unusually low, the conceptus may not be receiving enough 
nourishment to continue growth. Miscarriage, or spontaneous abortion, ensues if the hormone is 
unable to carry out the various tasks necessary to maintain pregnancy. This happens in 10-30% 
of pregnancies before the end of the first trimester (week 13)—often before the carrier even 
knows they are pregnant. Spontaneous abortion can occur due to a variety of factors, including 
chromosomal abnormalities, maternal age, thrombophilic disorders, immune dysfunction and 
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various endocrine disturbances.87 In each case, the body notices something is wrong and stops 
maintaining hormone levels, so the embryo stops growing. Knowing the crucial role of 
progesterone, many researchers have investigated whether supplements can prevent or reverse 
miscarriage. Overall, the results suggest that they do not improve outcomes, save for some 
evidence that supplements reduce risk of spontaneous abortion in people with a history of three 
or more miscarriages. Recurrent miscarriage is but one type of miscarriage among many. The 
rest are worth elaborating, as the differences will help us understand how MA fits into the 
picture.  
i. Threatened miscarriage: the body shows signs of potential miscarriage, such as low 
hCG levels, some vaginal bleeding or abdominal pain. The cervix remains closed, and 
symptoms may last weeks. This may progress into an inevitable miscarriage, or it 
may resolve into a healthy pregnancy. 
ii. Inevitable miscarriage: may either happen after a threatened miscarriage or come out 
of the blue. Bleeding and abdominal cramping is much greater, and the cervix opens 
for the conceptus to be expelled with the blood. 
iii. Complete miscarriage: has occurred when the conceptus and all of the uterine lining 
has completely left the uterus. Bleeding may persist for days, and extremely intense 
cramping pain is common. 
iv. Incomplete miscarriage: some of the pregnancy tissue remains in the uterus. 
Continues bleeding and cramping is likely as the uterus tries to expel the remnants. 
v. Missed miscarriage: in this case, the conceptus has stopped growing but the uterus 
has not begun to expel the pregnancy. Ceased symptoms of pregnancy and a brownish 
discharge are common signs. 
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If an incomplete or missed miscarriage occurs, follow-up treatment is necessary to help the body 
pass the pregnancy tissue. Physicians can either perform a D&E or provide medication to take at 
home—the same medication used to induce abortion. The medical standard is to treat incomplete 
and missed abortion at 12 weeks or less gestation with 800ug misoprostol, though a recent study 
found better outcomes when mifepristone was taken as pretreatment.88 These pills are prescribed 
because they mimic the mechanism of complete miscarriage in a safe and effective manner. It is 
for this very reason that they work so well as abortifacients. 
 When mifepristone and misoprostol are used in a combined regimen, there is a 98% 
chance that the abortion will reach completion. Mifepristone is a synthetic hormone antagonist 
with both antiprogesterone and antiglucocorticosteroid properties, working at the receptor level.89 
It acts on uterine progesterone receptors, which normally bind to progesterone to activate the 
transcription of various protein-coding genes. When mifepristone binds to a receptor, it induces a 
conformational change that prohibits progesterone binding, rendering the receptor inactive.90 
This interrupts the signaling pathway and impedes the synthesis of proteins with vital functions 
in pregnancy maintenance. As a result, the uterine lining begins to break down, the embryo 
receives inadequate nourishment and hCG levels decrease. Much like in miscarriage, 
progesterone can no longer keep the cervix firm and prevent uterine contractions, making it 
easier for the embryo to be expelled. Mifepristone also functions as an antiglucocorticosteroid, 
blocking glucocorticoid receptors. Negative feedback induces the anterior pituitary to secrete 
corticotropin (ACTH), which in turn stimulates the adrenal gland to secrete cortisol.e  
                                               
e Mifepristone’s antiglucocorticosteroid effect makes it useful for the treatment of Cushing’s Disease, which is 
characterized by overproduction of ACTH by the pituitary gland. By antagonizing cortisol receptors, mifepristone 
blocks the effect of excessive cortisol.  
Source: Raymond, Klein and Dumble, 1991. 
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To optimize its efficacy for terminating pregnancy, scientists sought to minimize the 
antiglucocorticosteroid effect and maximize the antiprogesterone effect. Misoprostol, the 
prostaglandin of choice, works by softening and dilating the cervix while inducing uterine 
contractions, thereby complementing the mechanism of mifepristone, which is more effective at 
stopping further development than expelling the pregnancy tissue. Misoprostol’s evacuative 
effect makes it optimal for treatment of incomplete and missed miscarriage as well as for 
cervical ripening prior to surgical abortion or gynecological procedures. In smaller doses, it can 
also be used to induce labor.91 Misoprostol is frequently used alone, as it is OTC in much of the 
world and is less expensive than mifepristone. Side effects for the misoprostol-only and 
combined approach are similar, but they are more intense when misoprostol is used alone. 
Risk v. Regulation 
Overall, the side effects of MA are minor and similar to those of a miscarriage, including 
bleeding, uterine cramping and pain. About 85% of patients additionally report at least one of the 
following side effects: nausea, vomiting, weakness, diarrhea, headache dizziness, fever and 
chills.92 With the combined approach, the continuing pregnancy rate is less than 0.5%, and 
abortion usually occurs within 3.5 hours of administering misoprostol.93 Because it is a non-
invasive procedure, MA does not come with risks of surgical abortion such as cervical injury and 
uterine perforation. Research also suggests that MA carries a lower rate of endometritis (from 
infection); large trials have shown rates varying from 0.1%-0.9% for MA and 0.1-4.7% for 
surgical abortion.94  Though deaths from abortion are hard to estimate, the best numbers suggest 
a rate of one death per 100,000 MAs through the ninth week of pregnancy.95  In comparison, five 
men die from Viagra-related drug reactions out every 100,000 prescriptions written,96 and there 
are 17.2 pregnancy-related deaths in the U.S. per 100,000 live births. 97 Abortion pills are, in fact, 
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some of the safest modern medications on the market, with complication rates lower than those 
of many widely used drugs such as Tylenol, Ritalin, Flonase Nasal Spray and Xanax.98 
The long, proven track record of MA leaves little room for questioning whether it is a 
safe and effective way to terminate pregnancy. As we will discuss in greater detail later on, there 
are many other reasons a woman might choose MA over another type of abortion (it can be used 
very early on, there is no need for anesthesia, it is noninvasive, etc.). These advantages have not 
gone unnoticed in the US. Since FDA approval in 2000, MA went from accounting for 0% of 
legal abortions to 39% in 2017.99 This is despite the REMS that limit distribution to specific 
providers and settings, thus creating insurmountable barriers within the formal health care 
system for many who would otherwise formally seek or provide MA. Abortion activists are not 
the only actors who see inconsistencies between the REMS and MA’s safety record. In 2017, an 
expert panel of researchers in the Mifeprex REMS Study Group made the same conclusion, 
arguing that the REMS place an unfair burden on those seeking access and on the health care 
system. Physicians, too, largely agree: “This shouldn’t be a political decision. It should be based 
on science, which has very clearly shown this is a very safe drug, safer than ones that don’t have 
this restriction,” explains Dr. Daniel Grossman, director of Advancing New Standards in 
Reproductive Health at the University of California San Francisco (UCSF).100 Several leading 
medical organizations also support lifting them, including the AMA, ACOG, and the American 
Academy of Family Physicians (AAFP). 
“15 years of use of mifepristone for induced abortion has not just proven it to be safe and 
effective, but have also supported an evidence-based regimen that improves care and the 
personal experience for women who find that it is the right choice for them… The REMS 
requirement is inconsistent with requirements for other drugs with similar or greater risks, 
especially in light of the significant benefit that mifepristone provides to patients,”—Mark 
S.DeFrancesco, MD, MBA, President of ACOG.101 
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“RESOLVED, That our American Medical Association support efforts urging the Food 
and Drug Administration to lift the Risk Evaluation and Mitigation Strategy on 
mifepristone.”102 
“RESOLVED, That the American Academy of Family Physicians engage in efforts to 
overturn the Risk Evaluation and Mitigation Strategies (REMS) classification on 
mifepristone.”103 
If the FDA were to alter regulations to be consistent with research findings and recommendations 
from evidence-based practice, they would immediately allow its distribution through 
telemedicine and lift the provider certification requirement.104 The comparison between MA’s 
safety profile and those of drugs such as Tylenol and Viagra begs the next question: should 
Mifeprex be available OTC? A 2017 study co-authored by Dr. Grossman answered with a 
qualified yes, explaining that while research gaps must be filled to definitively determine 
whether the regimen meets FDA criteria for OTC sale, preliminary evidence is very 
encouraging.105 On the topic of self-managed abortion, he asserts: 
The limited data so far suggests women are doing this safely—and there is no question that 
use of these medications has contributed to a reduction in abortion-related mortality 
worldwide… From a purely medical perspective, it no longer makes sense to demonize 
women’s safe use of abortion medications at home.”106  
The discrepancy between risk and regulation is impossible to justify with legitimate science. 
Instead, MA opponents propagate misinformation. In a recent blog post, the anti-abortion 
organization Family Research Council wrote: “Few legal drugs wreak havoc on the human body 
like the chemical abortion pill… the patient is at an incredible risk of the extreme bleeding that 
has become the pill’s life-threatening signature.”107  Such organizations often claim researchers 
and activists propagate “misleading information about the real risks of the abortion pill 
regimen”108 and “downplay the excruciating process that awaits unsuspecting women.”109 In 
reading these allegations, I am reminded of those directed at feminists in the early days of 
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mifepristone’s development for “overenthusiastically” hailing mifepristone as a “miracle drug.” 
How has the rhetoric remained so stagnant despite leaps in scientific understanding of MA? 
 The debate has never been centered on factual evidence. Those invested in expanding 
reproductive autonomy saw mifepristone’s development as the “biggest breakthrough in the 
battle for reproductive choices since the development of birth control,” whereas those seeking to 
end abortion altogether declared it “chemical warfare against the child in the womb."110 One side 
proclaimed its safety before scientists had decisively ruled out the possibility of serious adverse 
effects, while the other exaggerated MA’s potential to cause serious harm. Before its safety had 
been consistently demonstrated, the dialogue became polarized along political lines. Thus, 
American politicians could not approach the matter of regulation objectively. The inconsistency 
between risk and regulation today, I argue, can be traced back to the early disjunction between 
rhetoric and reality. 
 But the stage had long been set for MA’s polarized reception. To fully understand how 
such medically unnecessary regulations materialized, we’ll need to explore the larger landscape 
of abortion access, whose borders can be traced through the dark history of reproductive control 
in the US. 
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Chapter Three 
An Ongoing Fight for Reproductive Control 
 
“Reproductive justice uses a human rights framework to draw attention to—and resist—laws 
and public and corporate policies based on racial, gender, and class prejudices. These laws and 
policies deny people the right to control their bodies, interfere with their reproductive decision 
making, and, ultimately, prevent many people from being able to live with dignity in safe and 
healthy communities,”111 
 —Loretta Ross, Reproductive Justice: An Introduction 
Previously, we established that current FDA restrictions governing access to MA are 
medically unnecessary, existing only to serve political interests. This is far from an isolated case, 
as abortion regulations have never come from an interest in women’s health. Rather, they are 
outputs of longstanding, unbalanced power dynamics between women who know what’s best for 
their bodies and actors who think they have a claim to making reproductive decisions for them.  
The “reproductive justice” framework, established by a group of black women in 1994, 
recognizes that not all women have suffered equally; populations furthest removed from 
institutionalized power have been the most vulnerable to abuses such as rape, forced sterilization 
and discrimination in health care. 112 Furthermore, their needs were widely neglected by the 
mainstream women’s rights movement led by their white, middle class and wealthy counterparts, 
who had a different set of priorities. In this chapter, I make the case that while Roe v. Wade 
granted the constitutional right to abortion, the premises on which it was decided ensured that 
nothing would be done to substantially shift the balance of reproductive power. As a result, the 
same populations targeted for reproductive injustices before Roe are disproportionately affected 
by barriers to access today. A familiarity with this history is crucial to understanding the 
subversive power of self-managed MA. 
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A Longstanding Struggle 
Current debates over the where MA belongs in the landscape of reproductive health care 
in the US arose from a complex history of reproductive control that began in the mid-nineteenth 
century. Before then, reproductive choices had generally been seen as private matters. There 
were no legal restrictions on contraception, and abortion was not considered wrong if it 
happened before the “quickening,” when, about halfway through pregnancy, a woman could first 
detect fetal movement.113 By the end of the century, however, every state had passed a restrictive 
policy, and the Catholic Church had equated abortion to murder.114 
This dramatic shift was influenced by a variety of factors. Between 1830-1870, the 
fertility rate of white American women plummeted, and the immigrant population escalated. 
Racist anti-abortion crusaders argued that banning abortion was the only way to ensure the 
“proper” balance of fertility rates between the “best” and “inferior” stock.115 Meanwhile, male 
doctors began organizing to seize the medical profession from midwives, forming the AMA in 
1847. In order to legitimize their claim to superior scientific knowledge,f the AMA argued that 
abortion was dangerous and morally repugnant in an attempt to cast the midwives who provided 
them as morally questionable and professionally inferior. In 1859, they passed a resolution that 
condemned the practice altogether, save for life-threatening situations.116 This hugely influential 
resolution, which catalyzed the change in state legislatures, was not about the health and safety 
of women, and it was not even aimed at eliminating abortions. Rather, it was part of the AMA’s 
effort to eliminate the competition of midwives—it was about power: 
“It will not get us anywhere to say that midwives do just as good work as the 
average doctor, which may be true. It should not be a question of the lesser of two 
                                               
f This claim was, in fact, wholly illegitimate. Physicians were guided by superstition, religious belief and ancient 
tradition rather than actual scientific knowledge. They went so far as to resist new scientific practices that 
challenged traditional methods 
Source: Martinelli-Fernandez, Baker Sperry and Mcllvaine-Newsad, 2009 
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evils. Neither is fit. We want something better, we want well trained doctors to 
attend to women in confinement.”117 
 
This excerpt comes from an article in the American Journal of Public Health, which targets death 
as singular example of midwifery’s inferiority and establishes the state’s interest in preventing 
the “awful loss of life and economic wastage.”118 Yet, once the AMA established the medical 
profession’s control over the procedure, the anti-abortion rhetoric subsided, and services 
remained available through the first half of the 20th century despite widespread criminalization.119 
 In the 1930s, six states had no abortion bans, and illegal abortions were rarely prosecuted. 
Even with growing concern over the mortality rates associated with illegal abortion—an 
estimated 10,000 women died annually over the decade—little was done to intervene with the 
underground scene. Legal abortion was also possible to obtain from physicians if the procedure 
was deemed “medically necessary,” a characterization loosely justified until the 1950s, when the 
site of medical care moved from home to hospital. In addition to the establishment of oversight 
and review boards, more vocal articulation of Catholic opposition contributed to a sharp decline 
in the number of legal abortions by the early 1960s.120 Simultaneously, state officials and 
physicians began using sterilization to control the reproduction of poor women and women of 
color without their consent. These forced sterilizations became increasingly popular in the 1960s 
to prevent the reproduction of the “unfit,” a eugenic classification which extended to drug 
addicts, prostitutes, criminals and people with cognitive impairments or mental illnesses.121  
 On the other side of the struggle for reproductive control were activists fighting to 
reclaim it. Feminists, doctors and allies joined forces to maintain abortion access through the 
underground movement, and estimates of the number of illegal abortions in the 1950s and 1960s 
reach 1.2 million per year. This period, just prior to the 1973 ruling in Roe v. Wade, was the era 
of “coat-hanger” and other “back alley” abortions frequently referenced in discussions of self-
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managed abortion. But some were actually provided by well-trained medical practitioners who 
risked fines, imprisonment, and loss of their licenses. Information about these services traveled 
by word of mouth, and various referral groups were established to connect women with 
competent, reliable providers. The Chicago-based collective called Jane was the most 
sophisticated of these counseling services. Eventually, they took their services to the next level, 
hiring their own doctor so that each component of the process could be carefully controlled to 
secure safety and secrecy. A woman seeking abortion services would call “Jane” and leave a 
voicemail, after which a “Callback Jane” would phone back to collect information that was 
passed on to “Big Jane.” The patient would receive counseling at one location, “the front,” 
before they were taken (sometimes blindfolded) to a second address where a doctor did the 
abortion. That is, until the Janes discovered that the “doctor” they hired wasn’t a physician at all, 
and said, “Well, the hell with it. If he can do them, we can do them.”122 Soon, they learned from 
him all the technical skills necessary to safely perform abortion and went on to provide over 
11,000 abortions in their four years of operation.123 
 By taking it upon themselves to learn safe abortion techniques, the Jane collective acted 
both to demystify the medical construction of abortion and to subvert imbalanced power 
dynamics between women and the medical establishment. They realized the barriers set up 
between patient and practitioner served neither woman’s needs or the needs of the situation but 
were instead “a function of disciplinary power and a means of hoarding both institutional 
authority and useful knowledge.”124 In The Story of Jane, former Jane member Laura Kaplan 
writes: 
“We were ordinary women who, working together, accomplished something extraordinary. 
Our actions, which we saw as potentially transforming for other women, changed us, too. 
By taking responsibility, we became responsible. Most of us grew stronger, more self-
assured, confident in our own abilities. In picking up the tools of our own liberation, in our 
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case medical instruments, we broke a powerful taboo. That act was terrifying, but it was 
also exhilarating. We ourselves felt exactly the same powerfulness that we wanted other 
women to feel.”125 
Jane enabled women to actively participate in their own care in such a way that denaturalized the 
condescending treatment many had come to expect from male physicians. By assuming complete 
control over the procedures, they empowered women who otherwise would have been dependent 
on illegal practitioners that charged, on average, four times the fee for much riskier services.126 
Jane’s exemplary safety record, unfortunately, was nowhere near representative of the larger 
underground. 
There were entire hospital wards dedicated to complications from unsafe abortion during 
the pre-Roe era. Death was a “common occurrence,” as explained by a physician who worked in 
one: “I saw chemical burns, as well as perforations of the bladder, vagina, uterus, and rectum. 
Some women came in with overwhelming infections or in septic shock.”127 The associated death 
toll and other complications disproportionately affected poor women and women of color; from 
1972-1974, the mortality rate for nonwhite women was 12 times higher than that for white 
women.128 Wealth also played a role—women with economic means could afford the services of 
skilled practitioners, while poor women were more likely to self-induce. A study in the 1960s of 
low-income women in New York City found that of the 8% who had attempted to illegally 
terminate a pregnancy, 77% attempted to self-induce and just 2% said a physician had been at all 
involved. Even if a woman could produce hundreds of dollars for the procedure, the costs of 
travel and lodging often made the economic barrier insurmountable—the year before Roe passed, 
over 100,000 women journeyed to NYC from their own state, half of whom traveled over 500 
miles.129 
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 When Roe finally did pass, it was not on feminist terms. Second wave American 
feminism—which was, itself, ambivalent about abortion being a movement issue at first—was 
but one of three streams of social movement organization that led to the 1973 decision. The 
medical profession was primarily seeking the freedom to practice medicine without government 
interference, and public health advocates aimed to end the public health crisis of unsafe and 
dangerous abortions that disproportionately affected poor women and minorities. Activism was 
an important driving force, but feminists had only recently united to press for repeal of abortion 
laws instead of reform. As Lucinda (Cindy) Cisler, a leading women’s liberation strategist at the 
time explained: 
“Proposals for “reform” are based on the notion that abortions must be regulated, 
meted out to deserving women under an elaborate set of rules designed to provide 
‘safeguards against abuse’… Repeal is based in the quaint idea of justice: that 
abortion is a women’s right and that no-one can veto her decision and compel her 
to bear a child against her will.”130 
Feminists made it impossible for the Supreme Court to ignore the issue by speaking out across 
the country about their scars from the illegal underground and by bringing mass lawsuits to state 
courts in the late 1960s and early 1970s. Even so, when Roe finally made it to the Supreme 
Court, physicians’ needs were prioritized over those of women seeking abortions.  In her study 
of abortion cases, Susan Behuniak describes finding an absence of patients’ concerns and 
experiences in the amicus briefs: “There are no first-person accounts of what abortion means (for 
better or for worse) for the women who have experienced it, no stories, no telling of the horror of 
what it was like to undergo an illegal abortion or how it felt to lack reliable information about the 
procedure.”131 She explains that the same result-oriented legal norms that muted the emotional, 
experiential knowledge of these women acted to amplify the voice of medical knowledge: “By 
defining abortion as a medical issue, physicians moved to the center of the case whether they had 
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official standing or not.”132 The feminist movement played a crucial role in advancing Roe to the 
Supreme Court, but it was ultimately overshadowed by the priorities of other actors. Essentially, 
“Roe holds that while the state may not interfere with the woman’s decision during the first 
trimester, the physician, a lack of physicians, or a lack of money may.”133 The ruling established 
physicians as required participants in the decision to abort and privileged physicians’ discretion 
over women’s rights. 
Roe v. Wade may have established the constitutional right to abortion, but it opened the 
door for various state-level restrictions. After the first trimester, it allows a state to restrict 
abortion for the sake of the mother’s health, and after the point of viability, the state may prohibit 
abortions in non-life-threatening situations. Justice Harry A. Blackmun, who wrote the majority 
opinion, offered this framework in response to arguments from The State of Texas. Counsel for 
Texas argued that human life begins at conception, and that even if a fetus is not a person—
which they argued it was—the state had a compelling interest in protecting the life of a fetus that 
requires prohibiting abortion. Though Blackmun declared the Supreme Court was not in a 
position to determine the point at which life begins, he acknowledged that at some point in 
pregnancy, the state’s interest became a sufficiently compelling reason to set restrictions on 
abortion.134 The trimester system has been criticized as “arbitrary,” as has the decision to set the 
cutoff for non-life-threatening situations at the point of viability, which is itself variable and 
continues to reach a lower gestational age with the development of medical technology. Thus, a 
woman’s right to abortion could be eclipsed by a doctor’s discretion and by the state’s 
“justifiable” interest in the health of the pregnant woman and in protecting a potential human 
life. Not only were feminists outraged, but so too were those who felt the Court hadn’t done 
enough to protect the “human life” that begins at conception. 
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In fact, the response to Roe v. Wade transformed American politics, generating the 
polarized debate that currently surrounds abortion. At the time of the 7-2 decision, neither major 
political party was strongly associated with either abortion rights or the anti-abortion movement. 
Of the seven Justices who ruled in favor of Roe, five had been appointed by Republican 
presidents (though one was a Democrat himself), and two had been appointed by Democratic 
presidents. Meanwhile, a Republican and Democratic president each appointed one of the two 
dissenters.135 In the following years, however, the fervent opposition among social and religious 
conservatives grew into movements that soon found a home in the Republican Party and helped 
get “pro-life” candidates into office.136 This alliance solidified quickly, and by 1980 the 
Republican Party platform included a call for “a constitutional amendment to restore protection 
of the right to life for unborn children.”137 As the Republican Party increasingly identified with 
anti-abortion movement, the more liberal Democratic party became firmly pro-choice. Ever 
since, presidents have sought to nominate Justices who would promote constitutional values in 
line with their own positions on abortion, putting the Supreme Court’s authority and 
independence from partisan politics into question. When the Court heard another landmark case, 
Planned Parenthood of Southeastern Pennsylvania v. Casey, in 1992, three Republican-
appointed Justices had joined since Roe, and they were expected to tip the scales toward 
overturning it. Instead, they reaffirmed it, explaining: 
“Only the most convincing justification under accepted standards of precedent 
could suffice to demonstrate that a later decision overruling the first was anything 
but a surrender to political pressure and an unjustified repudiation of the principle 
on which the Court staked its authority in the first instance.”138 
Casey didn’t overturn Roe, but it did severely weaken it. The 1992 decision did away 
with the trimester framework to assert that the state has an interest in protecting fetal life 
throughout all of pregnancy, not just after the point of viability. From then on, states have been 
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able to pass laws regulating abortion for two purposes—protecting potential fetal life or 
protecting a women’s health and safety—so long as it did not present an “undue burden” for a 
woman seeking pregnancy. As constitutional law expert Jessica Mason Pieklo said in an 
interview with Vox, "Casey opened the door for a whole host of restrictions that would have 
probably been unconstitutional under a straight Roe analysis."139 States could now use the guise 
of protecting women’s health to pass regulations that made it harder for providers to stay open. 
With an expanded toolbelt, lawmakers have continued what they began in 1973, passing a total 
of 1,272 abortion restrictions as of July, 2019.140 These bills have shaped the severely limited 
landscape of abortion access today. 
The Landscape of Restrictions 
 A recent policy analysis by the Guttmacher Institute organizes laws that restrict and 
protect access into six categories: 
Six abortion restrictions Six protective policies 
• Ban pre- or postviability abortions in 
violation of constitutional protections 
• Require in-person abortion counseling 
followed by a waiting period before the 
procedure (thereby requiring at least two 
trips to the facility) 
• Restrict Medicaid coverage for abortion 
• Prohibit the use of telemedicine to provide 
medication abortion 
• Limit access to abortion for those younger 
than 18 without parental involvement 
• Impose unnecessary and onerous abortion 
clinic regulations 
• Affirm a right to abortion in the state 
constitution 
• Establish a legal standard that protects 
access to abortion 
• Guarantee abortion coverage through 
Medicaid 
• Allow advanced practice clinicians to 
provide abortion by law or Attorney 
General Opinion 
• Mandate private health insurance plans 
cover abortion 
• Protect access to abortion clinics 
 
Each state is then classified on a scale of hostility (ranging from “very hostile” to “very 
supportive”) based on the number of policies in each of the two groups.141 
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Figure 3 shows that six states are very 
hostile, 16 states are hostile, seven states 
lean hostile, seven states are middle-
ground, nine states lean supportive, four 
states are supportive and one state is 
very supportive. These numbers reflect 
policies in effect as of April 1st, 2020, 
but Guttmacher ran the same analysis on 
the policy landscapes as of 2010 and 
2000 to illustrate change over time. 
 
The number of orange (very hostile) states quadrupled between 2000 and 2020, and complete 
lack of red in both maps signifies that no states were very hostile to abortion before 2010 
(Figures 4-5). The uptick in enacted legislation speaks to the impact of the 2010 midterm 
Figure 3. US abortion policy landscape, 2020. 
Source: Guttmacher Institute, 2010 
Figure 5. US abortion policy landscape, 2010. 
Source: Guttmacher Institute, 2020 
Figure 4. US abortion policy landscape, 2000. 
Source: Guttmacher Institute, 2020 
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elections—of those 1,272 abortion restrictions passed in the 46 years between 1973 and mid-
2019, 38%g were enacted after 2010.142 
But what exactly do these restrictions do? In all 40 states with physician and hospital 
requirements, the abortion provider must be a licensed physician, despite overwhelming evidence 
that with training, nurses, midwives and physician assistants are capable of competently 
providing the full range of abortion care.143 After specified points in pregnancy, 17 of those states 
require the involvement of a second physician, and 19 require the abortion take place in a 
hospital. In the 43 states with gestational limits, abortions in non-life-threatening situations are 
prohibited after a certain point in pregnancy—in just the first half of 2019, nine states passed 
laws to outlaw abortion after 6-8, before many women even know they are pregnant.144 21 states 
outlaw dilation and extraction (D&X), or “partial-birth” abortions, 45 states allow individual 
health care providers to refuse to perform an abortion, 37 states require that minors involve their 
parents in the decision, and 18 states mandate counseling prior to obtaining an abortion. While 
16 states pay for at least most medically necessary abortions for Medicaid enrollees, 33 states 
prohibit the use of state funds, and 12 states restrict coverage by private insurance. Finally, 27 
states require women to wait at least 24 hours between receiving counseling and the procedure, 
and half of these states effectively require the woman make two separate trips to the clinic.145 The 
ever-increasing volume of such laws has forced dozens of abortion clinics to shut down in recent 
years, and six states are left with just one clinic.146 As a result, distance to an abortion provider 
                                               
g This number comes from combination of publications by the Guttmacher Institute. In “Last Five Years Account for 
More Than One-quarter of All Abortion Restrictions Enacted Since Roe,” they call attention to the 288 restrictions 
enacted between 2011-2015, 27% of the 1,074 since Roe v. Wade. “Policy Trends in the States, 2017,” “State Policy 
Trends 2018,” and “State Policy Trends at Mid-Year 2019” provide the numbers for 2016, 2017, 2018 and mid-year 
2019: 50, 63, 27 and 58, respectively. 
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has become an increasingly significant barrier to access, as illustrated in a series of maps 
published in the New York Times (Figure 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 6. For 11 million American women, the nearest abortion facility is over an hour’s drive away 
Source: The New York Times, 2019 
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Since 2013, at least 275 abortion facilities have closed across the country (Figure 7). 
 
According to abortion providers, the onslaught of recent regulations has not decreased 
demand for abortion, but has instead increased distance patients need to travel as well as strain 
on remaining facilities. Deputy director of Hope Clinic for Women in Granite City, Illinois 
explains: “We’ve already had to shoulder a 30 percent increase… [w]e are kind of in crisis 
mode. I think there’s just a lot of anxiety and confusion, as the news changes every day, from our 
Figure 7. Nationwide, 275 abortion facilities closed between 2013-2018 
Source: The New York Times, 2019 
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staff and our patients.”147 Furthermore, roughly 40% of the nation’s 750 abortion facilities do not 
provide after 13 weeks.148 As of 2017, 89% of counties had zero abortion clinics, 38% of women 
were living in these counties, and people in 27 cities had to travel at least 100 miles to reach the 
nearest provider.149 
Uneven Burdens 
It should come as no surprise that distance is a greater barrier to access for low-income 
women, who are already more likely to live far from abortion facilities. An analysis by the 
Washington Post shows that nationwide, 22% of women living below the poverty would have to 
drive over an hour, compared to 18% of non-poor women.150 Though drive times vary 
considerably among regions in the US, this disparity is consistent. But even if the drive times 
were equal, distance would continue to disproportionately affect women who don’t have access 
to a car, women who lack money for gas or public transportation, and women who may not be 
able to afford taking time off of work or hire childcare for the time they’re away. These obstacles 
double in states that require multiple visits over multiple days, the states in which the majority of 
poor women who must travel over an hour live.151 Many are unable to afford abortion care once 
the expenses associated with travel are tacked on. For many others, cost is already an 
insurmountable barrier. 
Abortion is an expensive procedure in it of itself, ranging from $75-$1,633 (mean of 
$535) for MA, $435-955 (mean of $508) for vacuum aspiration abortions, $500-$3,000 or more 
for D&E, and $8,000-$15,000 for late abortions.152 Since the Hyde Amendment was passed in 
1976 to prohibit federal dollars from going to abortion in non-extreme cases, most people who 
rely on Medicaid must pay out-of-pocket—with the exception of those who live in the 16 states 
that cover abortion care with their own funds. Meanwhile, 47% of Americans would not be able 
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to afford a $400 emergency without borrowing or selling something, and 75% of abortion 
patients in 2014 were low-income.153 Studies assessing the impact of Hyde show that many poor 
women seeking abortion delay or forgo paying rent or utility bills or buying food, while others 
rely on financial assistance from clinics and family members or sell their personal belongings.154 
Too often, the delays that come with raising funds 
cause additional costs (abortion becomes more 
expensive as gestational age increases) which then 
leads to additional delays as women postpone the 
procedure to gather the extra money. What’s more, 
the (still low) risk of complication increases with 
gestational age.155 Because women of color are more 
likely to receive Medicaid than white women due to 
the link between socioeconomic inequality and 
racism and discrimination, they are much more 
likely to get caught in this relentless cycle of costs 
and delays (Figure 8). The Hyde Amendment 
ensures that abortion restrictions disproportionately 
affect the most vulnerable populations. 
Abortion-Rights Activists Respond 
There’s more to the landscape of abortion access than the accomplishments of those 
working to diminish it. With the surge of anti-abortion legislation has come a surge in abortion 
activism. On the latter side, a grassroots network of abortion funds has spread across the country 
to help women pay for abortion care and the associated costs, and a network of abortion doulas  
Figure 8. The Hyde Amendment falls 
particularly hard on women of color 
Source: Guttmacher Institute, 2016 
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has formed to provide patients with support. Also nationwide, abortion clinics and advocacy 
groups have been organizing to fight restrictions at every level of government, determined to 
make abortion and other reproductive health care services more accessible. A map published in 
The Nation illustrates a sampling of these organizations (Figure 9).156 In total, there are 79 
abortion funds and 35 abortion doula groups, and hundreds of abortion providers are members of 
the National Abortion Federation (NAF), which pushes education and advocacy efforts.157 There 
are also legal organizations—such as If/When/How, the American Civil Liberties Union (ACLU) 
and the Center for Reproductive Rights—that seek to fundamentally transform the landscape of 
reproductive rights. Another, National Advocates for Pregnant Women (NAPW), specifically 
works with and for pregnant people, with a focus on those most likely to be targeted for state 
control and punishment. Yet others, such as the Reproductive Health Access Project (RHAP) are 
working to integrate reproductive health care into primary care facilities. Planned Parenthood, 
Black Mamas Matter Alliance, RH Reality Check, Sister Song, NARAL Pro-choice America—
the list goes on. In addition to the work they do individually, these organizations band together in 
Figure 9. Types of abortion access activism taking place around the country 
Source: The Nation, 2019 (map produced by Josh Leeman) 
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networks such as All* Above All, which specifically aims to build support for lifting the Hyde 
Amendment. In response to Congress’s attempts to defund Planned Parenthood in 2015, the 
hashtag #ShoutYourAbortion went viral and soon evolved into a grassroots movement of 
storytelling to normalize abortion. There’s even a coalition focused on MA, Coalition to Expand 
Access to Mifepristone in the US (Mife Coalition). These organizations fight for much more than 
abortion rights. In collectively embracing the reproductive justice framework, they’ve launched a 
movement that goes beyond the tired “pro-life”/”pro-choice” debate, defined by the three 
principles of reproductive justice: “(1) the right not to have a child; (2) the right to have a child; 
and (3) the right to parent children in safe and healthy environments. “158 It recognizes that the 
human right to dignified fertility management, childbirth and parenting cannot be realized 
without access to certain prerequisites—community-based resources such as housing, education, 
a living wage and competent, compassionate health care. Truly achieving this world would 
require substantially shifting power dynamics that have outlived generations of activist efforts. 
Roe v. Wade was not a true win for women, and in many ways, it was a setback for 
reproductive justice. By framing the right to abortion as a negative right (the right to non-
governmental interference in the decision to abort) Roe did nothing to ensure services would 
actually be accessible. Yet, situating it within a right to privacy suggested access came with 
legalization, inspiring the mainstream abortion rights lobby that, by centering “choice” rather 
than access, effectively trivialized the effects of nonlegal barriers such as poverty.159 Every 
woman in the US technically has the “freedom to choose” abortion, but 58% live in states hostile 
to abortion.160 Moreover, Roe reestablished medical authority—parallel to the AMA’s seizure of 
abortion from midwives, this act was about power rather than health. Just as midwives were 
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more than capable of providing competent care before the medical takeover, women in the Jane 
collective had proven that safe abortion didn’t have to mean medicalized.  
Today, we’re facing the possibility of a new phase in the struggle for reproductive 
control, an era in which Roe’s protections cease to exist. Should the constitutional right to 
abortion be struck down at the federal level, many states hostile to abortion will ban it altogether. 
How exactly would this change the landscape of abortion access? In the following chapter, I 
argue that the shift might not be as dramatic as some envision. Yes, entire states will eliminate 
access to legal services, but as we saw earlier, six states have already shut down all but one 
abortion facility. Those already living in “post-Roe” realities are increasingly looking for 
alternative sources of abortion care, and health care workers, experts and activists are working 
around the clock to get the word out about self-managed MA. We’ll see that the services are 
attracting a much wider audience than would be expected if barriers to access were the sole force 
driving demand. What motivations do people have for seeking self-managed MA, and based on 
this, what uses could it serve beyond the context of a post-Roe world?  
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Chapter Four 
Within, Before and Beyond a Post-Roe World 
 
“The graphic was simple but gripping: a black background with a wire coat hanger floating in 
the middle over one all-caps phrase: THE END OF ROE. HuffPost's editor-in-chief Lydia 
Polgreen tweeted out the image on Thursday morning, one of a string of left-leaning media nods 
to the same conclusion: Justice Anthony Kennedy's retirement from the U.S. Supreme Court is 
the beginning of a certain end to legal abortion access in America,”161 
—Elizabeth Nolan Brown 
 Activity on both sides of the abortion debate escalated dramatically following the 2016 
presidential election. On the campaign trail, Donald Trump vowed to appoint Justices hostile to 
abortion rights, who would overturn Roe: “I will protect [life] and the biggest way you can 
protect it is through the Supreme Court and putting people in the court. And actually the biggest 
way you can protect it, I guess, is by electing me president.”162 Since he took office, Trump has 
successfully appointed two Justices, Neil Gorsuch and Brett Kavanaugh. Though Gorsuch took 
the seat of a conservative Justice who called on his colleagues to overrule Roe in Webster v. 
Reproductive Health Services (1989), Kavanaugh replaced Anthony Kennedy, one of the three 
Justices who wrote the controlling opinion in Casey that upheld Roe. When Kennedy retired, the 
Court lost its one swing vote, which anti-abortion activists celebrated months before the 
confirmation of Kavanaugh in October of 2018 officially raised the reversal of Roe as a 
possibility. If this were to happen, the legality of abortion would be up to individual states.  
Legal Preparations 
 Lawmakers have already begun preparing for the post-Roe era that may or may not come. 
In 2019, several states enacted laws that would protect or expand access to abortion, including 
New York, Illinois, Nevada, Maine, Rhode Island and Vermont. On the other hand, eight states 
have enacted “trigger bans” that could ban abortion almost completely if Roe is rendered 
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ineffective.163 Seven other states have laws that would restrict abortion as far as the Supreme 
Court would allow. Additionally, nine states have unconstitutional pre-viability bans that are 
currently blocked in courts, and nine retain total bans from before Roe that could be reinstated. 
Altogether, 20 states have laws that could ban all or nearly all abortions in the absence of Roe 
(Figure 10).164  
In response, people have started imagining what this post-Roe US might look like. Some 
invoke images of coat hangers and other back-alley methods from the pre-Roe era, but the reality 
would be much closer to Dr. Willie Parker’s assessment: “A post-Roe world would look a lot 
like the world we have now, only more harsh.”165 Dr. Parker provides abortion several states, 
including two that Guttmacher classifies as “hostile” and one (Mississippi) that is “very hostile,” 
with just one abortion clinic remaining. Abortion deserts already exist, and we already know how 
they affect women seeking abortion—disproportionately. A Middlebury study funded by 
Figure 10. Less than half of US states would protect abortion rights if Roe fell 
Source: Center for Reproductive Rights, 2020 
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Guttmacher found that if Roe were reversed (and all high-risk states banned abortion), travel 
distance to the nearest abortion provider would increase from 1-791 miles, with an average of 
249 miles, for 39% of women aged 15-44.166 Women who can comfortably afford to travel the 
distances required of them now will likely still be able to in this post-Roe scenario, unlike those 
who would barely be able to scrape the money together today. As we saw in the previous 
chapter, this is a pattern that has existed at every stage of the struggle for reproductive control. 
Just as access to illegal abortion before Roe was unequal, so too has access to legal services been 
since its passing, and so too would access be after Roe. Inequality has been a devastating 
constant in the continually shifting landscape of abortion care. 
The Middlebury study also found that if women responded to increased distances as women 
in Texas did after restrictions forced 22 of the state’s 41 abortion clinics to close, the national 
rate of abortion would fall by roughly 32.8% in the year following Roe reversal.167 But other 
researchers disagree—a paper published in the Journal of Health Economics suggests that even 
if entire states became abortion deserts, the effects on population measures of birth and abortion 
rates would be small at most.168  Interestingly, too, the decline in abortion rates following clinic 
closures in Texas did not come with a commensurate rise in the birth rate. Whereas the abortion 
rate fell 20.5% between 2011 and 2014, the birth rate rose by only 2.6% in counties that no 
longer had an abortion provider within 50 miles.169 Such a dramatic difference is not explained 
by the minimal increase in contraceptive purchasing behavior, and in an interview for the New 
York Times, co-author Corey White said: “Our best guess is that for people who didn’t give birth, 
they were going to other sources for abortions.”170 A growing body of literature suggests a role 
for self-managed abortion. 
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Demand for Self-Managed MA is on the Rise 
Several studies run in Texas have attempted to assess the prevalence self-managed abortion. 
In a 2012 survey of women seeking abortions in Texas, 7% of respondents reported having 
attempted to self-induce abortion prior to seeking care at a clinic.171 This number is supported by 
data from cross-sectional surveys conducted in 2012 and 2014, which suggest that 6.9% of 
abortion clients had tried self-managed abortion before going to a clinic.172 A statewide 
representative sample women of aged 18-49 was surveyed in 2015, and 1.7% reported that they 
had ever attempted to terminate a pregnancy on their own, while 22% reported at least knowing 
someone who had.173 But just as Texas isn’t the only place in the US that has faced a barrage of 
abortion restrictions, it is not the only place thought to be experiencing a rise in self-managed 
abortion. 
Data analyst Seth Stephens-Davidowitz had the idea to quantify the number of times people 
turned to Google for information about self-induced abortion, searching phrases such as “how to 
self-abort.” He writes: “Google searches can help us understand what’s really going on. They 
show a hidden demand for self-induced abortion reminiscent of the era before Roe v. Wade.”174 
Altogether, there were 700,000 searches in 2015h, including roughly 119,000 for the exact phrase 
“how to have a miscarriage,” 4,000 for directions on coat hanger abortions, and hundreds for 
even more harmful methods such as bleaching one’s uterus and punching one’s stomach. There 
were also 160,000 searches for unofficial sources of abortion pills, like “buy abortion pills 
online” and “free abortion pills.” To determine whether increased interest is related to the 
onslaught of restrictions since 2011, he compared relative rates of Google searches with the 
number of major restrictions enacted, using data from Guttmacher (Figure 11).  
                                               
h For comparison, he notes, there were 3.4 million searches for abortion clinics in 2015, and according to 
Guttmacher there are roughly one millions legal abortions annually. 
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When he broke this down by state, the results provided further support for an inverse relationship 
between demand for self-managed abortion and legal barriers to abortion access (Figure 12).  
While eight of the 10 states with the highest Google search rates are classified as either hostile or 
very hostile to abortion by Guttmacher, the 10 states with the lowest search rates were either 
middle ground or supportive. The state with the single highest rate was Mississippi—one of the 
states that, with one clinic standing, is practically an abortion desert today (Figure 12). 
Figure 11. Tougher laws, more searching 
Source: The New York Times (state laws by Guttmacher Institute; analysis of Google data by 
Seth Stephens-Davidowitz) 
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 Though these findings certainly indicate that demand for self-managed abortion is 
increasing, they are not conclusive. We don’t actually know whether the people searching 
Google were pregnant or were planning to use the information to end their own pregnancies. To 
investigate what their motivations and circumstances might be, researchers designed a Google 
Figure 12. Abortion at Clinics, or Somewhere Else 
Source: The New York Times (state laws by Guttmacher Institute; analysis of Google data by 
Seth Stephens-Davidowitz) 
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Ad that would provide a survey link to people looking for information on self-induced 
abortions.175 Over 32 days, the link was shown 210,000 times, clicked on 9,800 times, and 1,235 
people completed the survey. Of the respondents, 73% indicated they were searching because 
they were pregnant and did not want to be and 11% had ever tried to self-induce. Because the 
samples are not nationally representative, these findings cannot be generalized to all women in 
the US, and studies that did use such samples found rates much lower than 11%—one found that 
2.6% had ever attempted self-management, and another found that 4.6% had.176 Both of those, 
however, were conducted before wave of restrictive legislation that followed the 2010 midterm 
elections. Since that wave darkened the landscape of access, no nationally representative studies 
have been published. 
 These studies suggest that self-managed abortion did not go away when Roe went into 
effect, and as its protections are weakened, interest is rising. In states most hostile to abortion, 
demand seems to be increasing at a rate greater than in less hostile states. This is further 
supported by findings from a recent study that measured requests for abortion pills through an 
online telemedicine service, Women on Web (WoW).177 WoW is a Netherlands-based nonprofit 
initiative that began providing misoprostol and mifepristone to people living in countries where 
safe abortion is unavailable in 2006.178 When contacting WoW, women begin by filling out an 
online consultation form that asks questions about their medical and pregnancy history, 
demographic characteristics, and reasons for seeking the service. Because abortion is technically 
legal throughout the US, WoW does not provide services to its residents,i but it still receives 
requests. Over 10 months in 2018, 6,022 US women reached out to WoW, and from analyzing 
                                               
i WoW responds to women seeking care in the US with information about locally available abortion services and 
funds, self-management, online pharmacies providing mifepristone, and financial and logistical assistance with 
accessing services  
Source: Aiken et al., 2019. 
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their consultation forms, Aiken’s team found that 76% were living in hostile states.j The number 
of requests WoW received from women in the US increased drastically in the years leading up to 
this study; in 2015, just over 600 had reached out.179 Seeing this, WoW founder Dr. Rebecca 
Gomperts launched a separate service, Aid Access, that works the same way as WoW save for 
one key piece—it ships to the US.  
Demand for the service took off immediately, attracting 21,000 requests in the year 
following its 2018 launch.180 Six months later, that number had reached 37,000, and 7,000 
packages had been shipped.181 Around the same time Dr. Gomperts shared these numbers, the 
Guttmacher Institute reported a 7% decline in the nationwide abortion rate between 2014 and 
2017.182 Guttmacher cited an increase in the number of women electing to self-manage as one of 
the potential contributing factors, but proving this is a difficult task. Because women do these 
abortions at home without reporting them, traditional clinic-based surveillance cannot be used to 
develop national estimates. However, Guttmacher did receive some evidence of increased use of 
self-managed MA from facility-level reports; in 2017, 18% of nonhospital facilities reporting 
seeing at least one patient for a missed or incomplete abortion following self-induction, up from 
12% in 2014. Furthermore, these proportions were greatest in the South (21%), where access is 
most limited.183 It’s important to note that these data only capture cases in which women seek 
rarely-needed follow-up care. Incomplete or missed abortion occurs in less than 15% of 
abortions using misoprostol only and in 5% using the combined approach. Dr. Linda Prine, a 
family physician and Medical Director of RHAPk, says that “99% of the women who self-
manage their abortions have no need to seek any medical care afterwards.”184 Thus, we can 
                                               
j For reference, 58% of women aged 13-44 live in states hostile to abortion rights (see page 27). 
k Reproductive Health Access Project—first discussed on page 52. 
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reasonably assume that for every self-managed abortion counted in these facility-based reports, 
many more were successfully completed at home.  
Taken together, these findings indicate that rejection from the formal health care system 
has prompted many to seek alternative sources of abortion care, translating to a surge of interest 
in self-managed MA. For those who already live in post-Roe realities, illegally ordering pills 
from the internet may be the most viable route to safe and effective abortion, and many are 
taking this into account as they imagine a post-Roe US. As Jill Adams, executive director of the 
legal nonprofit for reproductive justice If/When/How, explains to The Cut: 
“It’s no longer the Chicken Little narrative, where if you pass restrictions, clinics will 
close, people will be forced to take matters into their own hands, and it’s certain death and 
destruction from there. Instead, abortion will become even less accessible, and some 
people will self-manage abortion and most of them will be perfectly fine.”185  
 
If Roe v. Wade is overturned or rendered ineffective, we will certainly see escalation in the 
demand for abortion pills on the gray market. Popular press outlets have been churning various 
versions of the story out one after another, with catchy headlines such as “Abortion After the 
Clinic,” and “Illegal Abortion Will Mean Abortion By Mail.”186, These stories may be largely 
correct in their characterization of a post-Roe world, but they sometimes fail to catch the nuances 
of self-managed MA by overemphasizing its usage as a last resort. 
Reasons for Seeking Self-Managed MA 
Dwindling access is not the only reason people are turning to online sources for abortion 
services. Though 76% of WoW’s requests came from hostile states, the other 24% were sent by 
women in states considered to have supportive abortion policy climates. Moreover, women in 
hostile states did not cite barriers to access as their motivation for seeking services significantly 
more than women in supportive states did; the majority (60%) of women in each group reported 
seeking pills online because of a combination of barriers and preference.187 As Aiken states: 
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“More people are seeking out self-managed abortion as a first choice,” she said. "There’s more 
than one model of ideal care for people now: Some people prefer to have their abortion in a 
clinic, and some prefer to do it at home. We need to meet people where they are.”188 Indeed, 
there a growing body of evidence suggests that while a number of barriers push women toward 
self-managed abortion, a variety of unique advantages actually draw many toward it. These 
studies largely use interview-based methods, as personal testimony is the only way to capture the 
complex decision-making process behind the choice to self-manage.  
Among preferences, privacy is often cited first. With self-managed MA, women have the 
ability to hide the abortion from any family, friends, partners or health care workers who might 
be opposed or try to interfere. Because the symptoms and treatment mimic early pregnancy loss, 
and there is no medical test to determine whether someone has taken abortion pills, it is possible 
to disguise the abortion as a miscarriage. 
"... I was thinking especially about privacy. Using Cytotec is something that is yours, 
nobody has to know what you did or didn't do, no one invades your privacy. Even the 
gynaecologist I went to later didn't know that I had had an abortion," —Ana Cristina, age 
31.189  
"... I didn't want him [boyfriend] to know, and I didn't have the money, even though that 
wasn't the main reason. I wanted something fast and safe. In fact, I didn't even think of 
going to a clinic because I'd just got pregnant and I thought that there would be no 
problem with Cytotec,” —Fatima, age 27.190 
The convenience of ordering online and the comfortability of going through the entire process at 
home are also frequently cited motivations. 
"... I thought about going to a clinic, but it was too expensive and I would have had to plan 
it, go there, set the date, pay on the date. But not with the medicine, it's there in front of 
you, either you take it or you don't,” —Dilma, age 19.191 
“In a clinic, it's more—clinical, you know... You have people walking back and forth, you 
have people opening up the doors when you're in there and there's just no privacy, it's 
more hard... harsh... As opposed to being at home, you're in your own environment, you're 
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surrounded by things that make you feel safe and make you feel comfortable.” —Boston 5, 
age 20.192 
People who have negative experiences and associations with the health care system, who are 
afraid of doctors, or who generally prefer to have a less medicalized procedure, may be driven to 
avoid clinics altogether. 
“I don't want to deal again—and the questioning and to test me for STDs... and it's this big, 
long process... I don't want to have to go through that [again] if I don't have to.”  —San 
Francisco 1, age 21.193 
“I was scared... to actually go to a doctor and maybe they'll do worse than what, you know, 
I was going to do,” —New York 2, age 18.194 
For others, taking medication is a less traumatic experience than surgical abortion, both 
physically —it requires going under anesthesia—and psychologically. The process is often 
described as feeling more “natural.”  
"It's less traumatic, a lot less. You know what the sensation is? The sensation you have is 
that your period is late and so you take medicine for it to come. That is the feeling I had. I 
can lie to myself if I want, but I won't. I did it feeling good. I am not a liar to say such a 
thing, that I simply took some medicine, that I didn't cause an abortion," —Fatima, age 
27.195  
"I think that the effects of abortion, even though you are in favour of it, have always 
bothered me. It's traumatic, it's a real operation. That's what counted. Cytotec was less 
traumatic,"  —Rosana, age 25.196  
"I never saw it as an abortion. Using Cytotec felt more like postponing pregnancy at the 
time, waiting a little longer for a new life to appear. Because if I had gone to a clinic, I 
would never have forgiven myself. I was already doing this with a lot of regret, with a tight 
heart, full of insecurity. I wouldn't have been able to face a clinic, not physically or 
psychologically. I was never in favour of the abortion. I always thought that if I had an 
abortion, I would carry it with me for the rest of my life,” —Nilce, age 18.197 
“It's not a baby already. It's just blood. So I don't feel like it's killing a baby, because it's 
just developing,” —Boston 4, age 22.198 
Yet others are drawn simply to end the unwanted pregnancy as soon as possible. Remember, MA 
is the only type of abortion that can be used from the moment a woman learns she is pregnant. 
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“You can do it fairly quickly... and you just... get your period, and you don't even associate 
it with a possible pregnancy... There's Plan B [emergency contraception]. I used that just 
when a condom broke... That was essentially the same thing,” —San Francisco 1, age 21.199 
"I couldn't wait for the thing to get too far advanced. When I found out, the pregnancy was 
already ten days along, so I said, the sooner we solve this problem the better it is for 
everybody. I'll take Cytotec,” —Ana Cristina, age 31.200 
There are endless possibilities, but I’ll mention one more preference that is frequently cited and 
crucial to realize: the feeling of empowerment that comes with being one’s own provider, 
autonomously making one’s own health decisions and having an abortion on one’s own terms. 
“As a woman, you are the authority on your body. You know the best about what your body 
should feel like. I think I should be able to make the decision as I see fit. I’ve successfully 
used natural or self-care remedies for many other things in the past. That is why having an 
at-home abortion makes so much sense to me. I definitely think that at-home abortions 
should be available to all of us.” —Janice, a 29 year-old from Montana.201 
 More often than not, personal preferences factor into the decision to self-manage an 
abortion.202 However, barriers to access do seem to be responsible for a larger proportion of 
increased demand. In both hostile and supportive states, women seeking services from WoW 
were over four times as likely to report doing so because of barriers only (30%) than because of 
preferences only (7%).203 In Aiken et al.’s study, the most commonly cited barriers were the cost 
of clinic abortion, the need to keep abortion secret, time off work or school, and distance to 
clinic, followed closely by state laws, perceived abortion stigma, difficulty finding childcare, 
protester harassment and intimate partner violence. Women have elaborated on these motivations 
to other researchers, who want to understand why people seek medications online even when 
legal options exist: 
"... I went to a clinic, but it would have cost a little more than my salary, so I thought: 
What now? I won't be able to do it that way..." —Marcia, age 23.204 
“I decided on an at-home method for the fact that I didn’t want to be going out to a clinic 
where I know there’s a lot of protestors or things like that and I didn’t want to be dealing 
with them telling me that I wasn’t doing the right thing ... Even though I did have access ... 
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But I guess I didn’t want to tell nobody ... I guess I didn’t want to make it more public than 
what I -- because of all the media and stuff like that about like you shouldn’t abort and 
things like that,” —30 year-old from Texas.205  
“It’s going to become.... too far along, where the price increases, and I was like I’ve just 
got to get it done now. And I just said well, there’s only like what—I think there’s less than 
ten clinics in all of Texas now and they’re going to be busy. So when I call to make the 
appointment, you know, I couldn’t—I think the earliest they saw me was like a month from 
when I called because they’re so busy, you know.” —26-year-old, Corpus Christi.206 
“Originally, I had Googled abortion clinics near me, but when I started calling a bunch of 
them, they were like ‘No, we don’t do that.’ I found out that every clinic in Louisiana 
except three have been shut down. So, my next thought was ‘I need to do this on my own,’ 
and you can buy anything online, so my second thought was basically to order an abortion 
kit online.... I’m hours away from a clinic, and I would literally have to go through 
counseling at 8 a.m. and then stay there seven hours to speak to a doctor and get an 
ultrasound. And after that, I’m gonna have to have another consultation to get the abortion 
done, and then a third appointment to see how I am physically and emotionally. They are 
gonna make me listen to the heart-beat, they’re going to make me have counseling, and 
then I have to watch a video, and I just feel like that’s a bunch of bullshit. I know what I 
want, but the laws in the state make it so hard.”207 —anonymous 
“I found it really, really difficult to get information on what clinics provide. It’s hard 
having to call people directly and ask ‘Do you guys offer this?’ because there’s so much 
stigma attached to it. It would be so much easier if abortion were listed, just like every 
other service they offer in the clinic. So, I Googled ‘medical abortion.’ I came across the 
site [of the online telemedicine service], and it seemed like such a cool service where they 
would mail the medication,” —Marianela, a 32 year-old from California.208 
Some people who opt for self-managed abortion truly would prefer clinic-based care. As a 24-
year-old from Texas said, “I’ve got to say the surgical abortion’s a lot more comfortable so I 
would rather do it that way if I had to get another one. But money, it is a big deal and 19 dollars 
is a hell of a lot better than 400.”209 Cost was the primary prohibitive factor for another woman 
living in Texas, who ended up using misoprostol at 13 weeks’ gestation (at which point MA is no 
longer recommended) and hemorrhaged, requiring a D&E and blood transfusion. She 
commented:  
“If I knew all this would happen, I probably still would do it, because I would have had no 
choice but to do it, because I didn't have the money... But, if I had the money? Well, of 
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course, I would go probably to a regular clinic or something. But, if I was put in the same 
exact situation all over again? I'd probably do it again.”210 
Though a simple harm-reduction framing of self-managed MA is problematic, it is true that in 
some cases, the pills prevent people from turning to more dangerous options: 
“No doubt I would have ended up hurting myself. I honestly would have got the hanger in 
there. I would have done something physical to myself to get the baby out of my body. I 
wouldn’t have been able to cope with carrying to term. I absolutely would not have been 
able to,” —Sonia, 21 year-old from Michigan.211 
 “I was really desperate. I heard you could try drinking gin. I found YouTube videos that 
tell you how to do it with a hanger. Once he started explaining what you’re literally doing, 
I was shocked. I’m not gonna lie—it made me cry. Because if you’re young and you’re 
desperate, it’s like, you live in this space where you will go that extreme,” —Jovita, a 23 
year-old from Illinois.212 
These testimonies only begin to uncover the range of circumstances that compel women to 
choose self-managed MA, yet it is immediately clear that no single narrative or shared 
experience exists. This is what sometimes gets lost in the rush of popular press materials that cast 
it as the starring role in a post-Roe world. In doing so, it is easy to insinuate that its primary use 
is as a last resort only to be used when clinic abortions are unavailable. But this is simply not the 
case; while it may be a less desirable option for some, it’s a first choice for others. Some articles 
capture this nuance beautifully, such as Emily Shugerman’s “What Back Alley? These Women 
Say DIY Abortion Can Be Empowering.”213 Still, the larger implications of self-managed MA 
for understandings of safe abortion and reproductive autonomy are missed.  
Implications for “Safe Abortion” and Reproductive Autonomy 
 Back in Chapter One, we saw that new relationships between the terms “self-managed,” 
“safe” and “legal” prompted WHO to redefine their formerly dichotomized concept of safe 
abortion, now described as a continuum of risk that takes social and legal context into account. In 
a 2018 commentary, Joanna Erdman, Kinga Jelinska and Susan Yanow expand on these dynamic 
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relationships by examining, as the title suggests, “Understandings of self-managed abortion as 
health inequity, harm reduction and social change”— three frameworks through which to view 
the practice. They explain that inequities in abortion are constructed; outcomes tend to fall along 
race, age and class lines, but they are not inherent to those social markers and cannot be 
attributed to a lack of wealth or knowledge. Rather, the social resources of wealth and status are 
only necessary to access formal care due to “legal and policy structures that marginalize people, 
create vulnerability and impose disadvantage in accessing safe abortion care.”214  
Recognizing this, recent studies have aimed to redefine the causes of inequalities by 
focusing on barriers to clinic-based abortion care—barriers we’ve discussed at length along with 
their disproportionate effects. Though important research, Erdman, Jelinska and Yanow critique 
these studies for retaining the clinical setting as the standard and desired place of care. In doing 
so, they “[ignore] the too common mistreatment and abuse of abortion seekers within formal 
health care systems, where providers may believe they have a moral if not legal right to accuse, 
judge and condemn.”215 As we learned from testimonies in the previous section, clinic-based 
abortion care can also entail rounds of questioning, STD testing and encounters with anti-
abortion protesters that are felt as dehumanizing. Moreover, women have described their 
experienced safety of abortion care in terms of social and economic security in addition to 
physical safety.216 Thus, by making it possible to avoid the indignities of formal settings and 
associated feelings of shame and powerlessness, self-managed MA can offer a unique, enhanced 
experience of safety. Safe abortion interventions that aim to combat health inequities by reducing 
barriers to clinic-based care have yet to take this into account. 
 I’ve cautioned against narrowly framing self-managed MA as harm reduction, but it is an 
important application of the practice. After all, WHO decided to recommend the miso-only 
 Matthews 72 
protocol (when mifepristone is inaccessible) in its updated guidelines for safe abortion because 
its use had already been linked to reductions in complications from unsafe abortion. Our brief 
journey into the history of self-managed abortion revealed the lengths to which women have 
willingly gone to end unwanted pregnancies, and the advent of MA means that no one should 
have to suffer or die from these efforts. Within the harm reduction framework, safe abortion 
interventions are designed to increase access to accurate information and quality medicines.217 
These include professionalized information programs, which are measured and assessed by 
public health impact, as well as feminist-run websites and hotlines. Networks of volunteers also 
provide in-person support by accompanying people as they buy and use the medications.  
In addition to providing practical information about the regimens and counseling on how 
to manage the side effects, these interventions aim to help people avoid legal consequences. This 
is perhaps their most significant role given that the risks of self-managed MA are primarily legal 
rather than health-related. These interventions include security measures of encrypted or 
anonymous information as well as informing women that MA cannot be medically distinguished 
from miscarriage, allowing them to seek follow-up care without the fear of arrest. Furthermore, 
they are rooted in the principles of reproductive justice, best explained by Erdman, Jelinska and 
Yanow: 
“These harm reduction interventions do not simply respond to structures of inequity that 
render SMA risky or unsafe. They seek to actively disrupt these structures and to minimise 
if not eradicate the social inequities sustained by them. These interventions are grounded in 
the basic human rights to seek, receive and disseminate information and ideas on sexual 
and reproductive health, and to enjoy the benefits of scientific progress, specifically in 
access to misoprostol and mifepristone as essential medicines. These are claims not merely 
of freedom from state restraint, but collective rights for all, including disadvantaged and 
marginalised groups, to a full range of sexual and reproductive health care, including 
technological advances and innovations in the provision of sexual and reproductive health 
services, such as medication for abortion.”218 
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Because marginalized groups are most at risk from regulatory laws that can be used with 
discretion, harm reduction interventions fundamentally support legal reform and 
decriminalization. 
Social change is thus a third frame in which we must consider the implications of self-
managed MA. Physicians, feminists and researchers have called for changes to restrictions that 
serve no medical purpose and violate women’s constitutional and human rights. Much like the 
Jane collective did in the years leading up to Roe, feminist groups organizing around self-
managed MA operate independently from the health and state institutions whose power derives 
from the suppression of women’s reproductive control. Medical and state-based authority has 
limited the terms and conditions of abortion access and suppressed demedicalized 
conceptualizations of abortion. Conversely, grassroots efforts to spread information flatten 
hierarchies of authoritative knowledge and subvert unbalanced power dynamics: “[self-managed 
MA] is subversive precisely because it challenges assumptions about service delivery 
requirements, definitions of who/what is a provider of care and the power dynamics of care.”219 
When a woman becomes the “provider,” she is able to control the process with the level of 
support she deems appropriate from those sharing information about how to use and access the 
pills; her capacity to act autonomously is greatly increased.  
The practice of self-managed MA can also be empowering for everyone who participates 
in the collective activism that makes it possible. Learning the science behind MA and being able 
to support others as they self-manage is self-empowering, which translates into local activism 
that in turn helps to normalize abortion, advocate for its decriminalization and break taboos 
around women’s sexuality.220 The local ownership established by those who assume roles in 
distributing the pills is also a powerful act of resilience, and by inspiring local activism while 
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connecting national and regional advocates, it “creates the potential for systemic change and 
increases sustainability.”221 We can again see parallels to the Jane collective here, whose 
members described picking up medical instruments, the tools of their own liberation, and feeling 
a sense of transformative power that they strived to share with other women.222 Over hundreds of 
years, women have again and again demonstrated their ability to take matters into their own 
hands—as well as their awareness of the consequences and willingness to live with the worst of 
them—yet they still are not trusted to make decisions for themselves. As Laura Woliver writes in 
The Political Geographies of Pregnancy, “The idea that women are experts on their own 
experiences has typically been dismissed.”223 The feminist groups organizing around self-
managed MA, however, understand that each individual has a unique set of values and priorities 
that leads to entirely unique experiences, and they “refuse to label and to thereby judge the act of 
abortion by any terms other than how an individual experiences it.”224 Thus, their actions both 
liberate abortion from medical control and redefine expertise as experiential rather than legal or 
medical. 
There is no question that self-managed abortion is happening now and is here to stay. 
Indeed, it is likely to increase in popularity over the coming years, and if we do find ourselves 
living in a post-Roe US, collective efforts to spread information will be crucial to minimizing the 
damages of unsafe abortion. Even—and especially—in this context, it is crucial that we are able 
to understand self-managed MA as harm reduction without thinking of it as “less unsafe” or a 
“last resort,” as some would choose to self-manage even if barriers to clinic-based care did not 
exist. Such a framing should also consider the ways in which the practice can enhance safety for 
those who have traumatic associations with the formal health care system, and it weakens the 
potential for social change by diminishing the subversive power inherent to the operation. But is 
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this capacity any match for the institutionalized power currently governing access to abortion 
and MA? At the end of the day, who really controls access to abortion pills, and what are their 
motives? In the following chapter, I will characterize various actors with a stake in this landscape 
and attempt to assess the nature of pivotal power dynamics. 
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Chapter Five 
Who Really Controls Access to Abortion Pills? 
 
“Using a slogan from ANT, you have ‘to follow the actors themselves’, that is try to catch up 
with their often wild innovations in order to learn from them what the collective existence has 
become in their hands, which methods they have elaborated to make it fit together, which 
accounts could best define the new associations that they have been forced to establish,”225 
—Bruno Latour, Reassembling the Social 
Today, a movement exists with the potential to substantially shift unbalanced power 
dynamics central to the struggle for reproductive control. Even when self-managed MA is not an 
explicitly political act, it challenges medical and state-based control of abortion as well as 
traditional understandings of “safe” in relation to “legal.” As more and more and more people are 
successfully navigating their way around medically unnecessary barriers imposed by REMS, the 
FDA’s authority as a regulatory agency is arguably threatened. Criminalization remains a risk for 
those who purchase the pills from unofficial sources, but as we know, activist networks are 
working tirelessly to spread information on how to minimize that likelihood. Will the subversive 
power of self-managed MA meet the same fate as that generated by the Jane collective, which 
faded once medical control was reestablished in Roe? If not, how might it manifest in the coming 
years? Answers to these questions hinge on power dynamics far more complex than those 
between woman and physician, or woman and state. The framework of ANT is useful here, as it 
exists to investigate networks of human and non-human actors that form associations around 
scientific innovations such as MA. We’ll “follow the actors," in this chapter, identifying some of 
the major players that influence use and distribution of MA and the interests that compel them to 
act. Because I am particularly interested in how power is exerted within this network, I use one 
case study, an ongoing legal battle between two such actors, to inspect these dynamics in action 
before attempting to assess their stability. 
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Mifepristone and Misoprostol 
 There are a number of qualities inherent to mifepristone and misoprostol, the abortion 
pills themselves, that are relevant to the roles played by surrounding actors. First, they allow for 
variation and flexibility in the administration protocol. WHO approves six different variations at 
less than 12 weeks’ gestation, depending on the availability of mifepristone and the preferred 
route of misoprostol administration (buccal, vaginal or sublingual). There are another six 
versions for pregnancies over 12 weeks’ gestation, with slightly different dosages.226 Efficacy is 
greatest at the optimal dosages recommended, but there is some leeway, as studies have shown 
similar efficacy at different doses of mifepristone and misoprostol, with some variation in side 
effects.227 This makes it illogical to require compliance with a singular protocol and important to 
spread information about the various options. 
These medications make the uterus do the work of expelling pregnancy tissue. The 
mechanism may be perceived as natural, as it mimics miscarriage and works from the inside out. 
Vacuum and D&E abortion rely on medical instruments and clinicians’ hands, whereas medical 
professionals have very limited access to the body parts involved in MA and no control over its 
progression. It is also important to note that pain is a normal by-product of the procedure and 
cannot be used as an indicator of how well or poorly it is progressing, which can be stressful if 
the woman does not know what to expect. Thus, communication with people knowledgeable 
about the process is crucial to care, and without a support network, the adverse effects of any 
complication can multiply. 
Women are never passive recipients of MA care, even when it is distributed in clinics. 
They must always be somewhat involved in the process, managing symptoms and monitoring the 
substances expelled from the body. Thus, the process is always self-managed to a degree, which 
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means that it will always be experienced as empowering by some, and it will always advance a 
more “natural,” demedicalized understanding of abortion. Because the pills do not work 
immediately, they enable the user to be mobile during the early stages, thus operating somewhat 
invisibly and privately. The physical pills are also quite mobile, as they are small and easily 
shipped or transported. Finally, they are very low tech and do not take significant training or 
expertise to administer, facilitating the shift of care from physicians’ hands to those of women 
and their support networks, the people most affected by the abortion. 
Women Who Seek MA 
Women play the crucial role of determining demand for MA. In addition to the growing 
practice of self-managed MA, the number of legal MAs provided in formal facilities has also 
risen steadily, as many of the same advantages apply (noninvasiveness, efficacy at very early 
Figure 13. MA increased from 5% of abortions in 2001 to 39% in 2017, even 
as overall abortion numbers declined 
Source: Guttmacher Institute, 2019 
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gestations, and lack of risks of uterine perforation, etc.). By 2017, MA accounted for 39% of all 
clinic-based abortions, which is still striking given the burdensome restrictions guarding access 
to MA (Figure 13).228 As we know, many more women have turned to online pharmacies and 
other unofficial sources to purchase abortion pills. By successfully self-managing their 
abortions—or at the very least, managing the symptoms and side effects at home—women are 
proving that safe abortion can exist beyond the walls of formal settings. Interest and demand for 
MA, both self-managed and not, is further increased as these women share their experiences by 
word of mouth, whether through activism or casual conversation. 
State Laws 
Clinic-based MA care is subject to the same state-level abortion restrictions as vacuum and 
D&E abortions, which we discussed in Chapter Three within the context of the history of 
reproductive control. Because it is a relatively new technology, the majority of abortion laws 
were written before MA became available. Consequently, many of these laws do not make sense 
in the context of MA but are enforced nonetheless. For example, though physician assistants and 
nurses are authorized to provide MA in some states, 33 states limit provision to physicians 
despite clear evidence that other health care workers are equally competent. In 18 states, the 
physician is required to be in the same room as the patient when providing the pills, effectively 
banning telemedicine abortion.229  
Additionally, a variety of targeted regulation of abortion providers (TRAP) laws single out 
abortion facilities by imposing regulations that do not apply to other health centers or physician 
offices. These laws that go beyond what is needed to ensure safety, imposing burdens that have 
forced hundreds of providers to shut down in recent years. For example, 11 states require that 
providers have some affiliation with a local hospital, nine states specify the size of procedure 
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rooms, eight specify corridor width and eight require facilities be within a certain distance from a 
hospital.230 TRAP laws deter facilities from providing MA when they would otherwise be able to 
do so. 
All forced parental involvement, counseling and mandatory delay laws apply to MA, 
requiring waiting periods to occur before mifepristone is administered.231 Recently, an increasing 
number of states have followed Arkansas’s lead in requiring providers to tell patients about MA 
“reversal”—a medically unsupported treatment that involves taking a high dose of progesterone 
after the first dose of mifepristone, allegedly to “save” the pregnancy. Proponents of this 
counseling claim it provides patients with options, but it in fact “uses flawed research to 
undermine personal reproductive health choices.232 
Twenty-six states have added to the standard crop of abortion laws to explicitly regulate 
MA (Figure 14).233 Some have updated legislation to formally include it in the legal definition of 
abortion, and others have either passed or are considering additional regulations that specifically 
target MA.234 Though medical consensus, which includes studies run by WHO, recognizes that 
the current FDA protocol is outdated, North Dakota, Ohio and Texas require physicians to follow 
its instructions precisely. Arkansas and Oklahoma passed similar laws that have been blocked by 
courts. There are also a number of states that have explicitly criminalized self-managed abortion, 
while others have laws that could be used to prosecute women for self-managing, ranging from 
fetal homicide laws to those that criminalize failure to report an abortion to the coroner.235  
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Enforcement of many of these laws largely falls on medical professionals to report women 
they suspect of self-inducing to authorities, and though understanding the legal landscape around 
self-managed MA can be both useful and empowering, where one is in the country might not 
make much of a difference. Susan Yanow uses the analogy of driving while black here—
hundreds of thousands of people have been wrongfully arrested and ended up in jail anyway. 
Similarly, marginalized groups are more likely to be accused of taking abortion pills in the ER or 
otherwise targeted; if there’s a will to criminalize self-managed abortion, there’s a law they’ll try 
to twist to serve the purpose. At least 20 women have been arrested and charged after an 
attempted self-managed abortion, but it remains very uncommon.236According to Jill Adams, 
Figure 14. Legal landscape around self-managed abortion 
Source: Guttmacher Institute, 2018 
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there is still no known case of someone in the US being arrested or investigated for the sole act 
of purchasing abortion pills online. She explains, “Importation of drugs is technically prohibited 
under federal law, but in practice it is not enforced against individuals for personal use.”237 
Physicians and Medical Groups 
 As we know, access to MA could be greatly expanded through primary care were it not 
for laws that make it unappealing to prescribe. Burdens are imposed by TRAP and “physician-
only” laws as well as the requirements that a doctor complete certification and enroll in a public 
registry of abortion providers. Dr. Linda Prine has helped RHAP train hundreds of clinicians 
through MA workshops. In just 90 minutes, the group is able to cover all of the necessary 
medicine, which she describes as straightforward. Yet, not everyone who gets trained actually 
goes on to become a provider. The difficulty, she explains, comes from implementation barriers 
such as state regulation and administrative blocking—if one coworker is against it, all of their 
efforts could be lost.238 
 Access could similarly be expanded through telemedicine, but the REMS and many state 
laws prohibit this use. As was mentioned in Chapter One, several leading medical organizations 
such as ACOG, AMA and AAFP have publicly opposed the REMS, and the expert panel of the 
Mifeprex Study Group came to the same conclusion. Dr. Prine says that she has yet to run across 
a medical professional who truly believes they’re in place to protect women’s health and safety. 
“They don’t serve any medical purpose,” she adds, “they’re just a barrier.”239 This position has 
emerged as the general consensus among physicians and medical groups. 
 There are certainly many physicians who oppose MA on religious or political grounds or 
disapprove of self-manage MA. Marge Berer writes: “some doctors just do not want to hand over 
the power of decision-making over who gets an abortion, and many, especially in the private 
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sector, will potentially lose a lot of income if they can no longer provide most abortions.”240 It is 
impossible to know just how much “business” would be lost to self-managed MA, but personal 
preferences would maintain a large degree of demand for clinic-based care nonetheless. Though 
there are still physicians who prioritize personal gain over the reproductive rights and autonomy 
of women, the emerging consensus and support of leading medical organizations suggests this 
proportion is lower than ever before. 
The US Food and Drug Administration (FDA) 
 In 2000, the FDA first approved mifepristone under the brand-name Mifeprex for use up 
to 49 days gestation. The agency updated the labeling in 2016, extending eligibility to 70 days 
gestation and modifying the dose of Mifeprex as well as the dosing regimen for Mifeprex and 
misoprostol.241 Since then, it has approved a generic version produced by GenBioPro, Inc. 
(2019), which is subject to the same Risk Evaluation and Mitigation Strategy (REMS) as 
Mifeprex.  
As previously discussed, a REMS is essentially a set of restrictions beyond the drug’s label 
that the FDA is authorized to impose only when it is necessary to ensure that the benefits of a 
drug outweigh its risks. The Mifeprex REMS has three core provisions. First, distribution is 
limited to providers in clinics, medical offices and hospitals. This prohibits pharmacies (both 
online and in-person) from dispensing the pills as they would for most other safe and effective 
medications. Second, the providers must become certified, which entails filling out a form saying 
they are qualified to assess pregnancy duration, diagnose ectopic pregnancy and provide or be 
able to refer the patient to surgical intervention if necessary.242 To complete certification, 
clinicians are required to enroll in a national registry. Third, patients prescribed Mifeprex must 
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sign an FDA-approved patient agreement that summarizes instructions on the label and potential 
risks.243  
 At the time of approval in 2000, documented clinical experience with MA was limited, 
thus the REMS precautions were perhaps justifiable. However, as we’ve already discussed, a 
strong and extensive safety record has since been established for Mifeprex. Our earlier 
comparison of risk and regulation confirmed that the risk strategy serves no medical purpose, 
leading to the conclusion that the REMS are maintained due to political interest; “playing 
politics” has suppressed MA’s potential to mitigate abortion inequities. 
Most of the FDA’s regulatory authority comes from the 1938 Food, Drug & Cosmetics Act, 
which empowered the agency to regulate testing, manufacturing, labeling, marketing, efficacy, 
safety and just about every other aspect of prescription drugs.244 Its enforcement powers include 
seizure, criminal prosecution, injunctions, warning letters and administrative procedures.245 The 
FDA is led by the Commissioner of Food and Drugs, presently Dr. Stephen Hahn, who reports to 
the Secretary of Health and Human Services, Alex Azar. Hahn stepped into the job with no prior 
political experience, and Azar is a former pharmaceutical executive who also served under the 
George W. Bush administration.246 Both were appointed by Trump, and both could be removed 
at his will.  
Online Unregulated Pharmacies 
 The ability to obtain prescription medications online is a relatively recent phenomenon 
that has grown exponentially in the past couple of decades. In 2015, the Federal Bureau of 
Investigation (FBI) estimated that over 80,000 illegal sites exist.247  Though some online 
pharmacies adhere to federal regulations, a random sampling by the FDA found that 97% do not. 
Meanwhile, one in four Americans buy their prescription drugs online for reasons such as 
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accessibility, time constraints and cost savings.248 Several studies have concluded that while 
international regulations and laws exist for online pharmacies, it is difficult, if not impossible, to 
effectively achieve regulatory oversight and enforcement.249 
 The main concern with obtaining medications via such pharmacies is the possibility that 
the drugs received will not contain the correct active ingredient in the proper amount. This is not 
a risk that proponents of self-managed MA have shrugged off. Rather, researchers associated 
with the activist network Plan C, which informs and supports those seeking abortion pills, 
tackled the issue head-on. Beginning in early 2017, they conducted a study to test the reliability 
of online pharmacies claiming to sell mifepristone and misoprostol. The team successfully 
obtained 18 combination products and two misoprostol products from 16 sites, documenting the 
price, shipping time and product quality. In each case, the mifepristone tablets contained within 
8% of the advertised amount and the misoprostol tablets usually contained less than advertised, 
but enough to be effective.250 Since then, Plan C has kept an ongoing “Report Card” of tested 
online pill providers. Eight high-quality providers are currently listed with grades ranging from 
A-C, prices ranging from $90-$430 (median $262) and ship times of two weeks or less. Only one 
website is overseen by a physician who fills prescriptions based on information provided: Aid 
Access, the only site to receive an “A.” It also charges the lowest fee per shipment ($90), which 
is often waived for patients who are unable to come up with the money.  
Activist Networks 
 Though Aid Access provides patients with all the information they’d need to safely and 
effectively carry out their own abortion, most online pharmacies do not. Several activist 
networks have taken the initiative to fill in these gaps. Plan C not only educates the public and 
researches new routes of access in the US but also mobilizes a grassroots network of activists 
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fighting to make self-managed care a mainstream option.251 Women Help Women (WHW) 
similarly works to change social norms and increase access to abortion through direct action. The 
group partners and collaborates with organizations around the world to train activists, conduct 
research needed for evidence-based advocacy and establish hotlines for those self-managing.252 
In 2017, the group launched Self-Managed Abortion; Safe and Supported (SASS) to help people 
navigate the confusing patchwork of laws surrounding abortion pills and minimize legal risk. 
WHW is a member of several networks working to destigmatize, demystify, decriminalize and 
demedicalize abortion pills. Spreading information to rural and underprivileged populations is 
both a challenge and a priority for activists. Susan Yanow, cofounder of WHW describes the 
group’s attempts to utilize social media, Google and Facebook ads as expensive and not 
particularly successful. On the other hand, she is encouraged by quantity of people WHW has 
reached through train-the-trainer workshops.253  
 There are many more organizations like WHW and Plan C, within the US and around the 
world, working to spread knowledge and power in every language possible to complement the 
services provided by online pharmacies. These organizations are not fighting for a world in 
which all abortion is self-managed but for a world in which all women have the option. As 
Yanow explains, “There’s no ‘one size fits all.’ Self-managed abortion is not a silver bullet, it’s 
not a panacea.”254 The movement recognizes that many people, for a wide variety of reasons, will 
still choose to receive care from a provider, but believes it is their human right to make the 
decision for themselves. It calls for access to self-managed MA within the full spectrum of 
abortion care, as research supports its safety for use through telemedicine and pharmacies. 
Pointing to the people using the pills safely all around the world, Yanow asserts that regulations 
governing their use are not necessary from a medical safety perspective. The only regulations 
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necessary, she adds, are those which guarantee the quality of medicines and accuracy of 
information channels—there is a difference between free speech and intentional 
misinformation.255 
Case Study: FDA v. Aid Access 
 As a regulatory agency of the federal government, the FDA’s authority is called into 
question by online unregulated pharmacies shipping abortion pills to the US. This has recently 
manifested in a legal battle between the two actors, initiated by the FDA in March of 2019 with a 
warning letter. In the latter, Aid Access is accused of violating federal law and ordered to 
immediately cease the "sale of misbranded and unapproved new drugs [which pose] an inherent 
risk to consumers who purchase those products" or face the consequences of “regulatory 
action.”256 The letter was applauded by 117 members of Congress, all of whom are Republican 
and 92% are male.257 In response, Dr. Gomperts stopped prescribing the pills to US patients for 
roughly two months before resuming business as usual. As she said in an interview with NPR, 
"The FDA is a huge institution. It's very powerful, and it's a form of intimidation that is quite 
severe… I would say a form of bullying. And so I think it's very important to stand up against 
it."258 
Not only did Dr. Gomperts defy the FDA’s orders, but she and her lawyer Richard Hearn 
retaliated. Hearn responded to the warning letter, denouncing the FDA for writing it and thereby 
violating the constitutional rights of Dr. Gomperts’s patients. He claims the FDA lacks 
jurisdiction over Dr. Gomperts’ practice and concludes that “[u]ntil the REMS restrictions 
imposed by the FDA on access to misoprostol and mifepristone are lifted, women seeking to 
terminate their pre-viable pregnancies in the U.S will be forced to exercise their constitutional 
right to choose by way of the internet.”259 Soon after, several of her shipments were seized and 
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payments blocked, and Dr. Gomperts responded by suing the FDA. The lawsuit states that (1) for 
many women, the only practical option for women seeking to terminate unwanted pregnancies is 
found on the internet, (2) Aid Access helps such women exercise their constitutional right to safe 
abortion prior to viability, and (3) the FDA is actively using the power of the US federal 
government to deny this right.260 Hearn said the goal of the lawsuit is to force the FDA to stop 
interfering and to prevent Gomperts or her patients from being prosecuted under federal law.261 
Clearly, Aid Access’s argument relies on the status of Roe v. Wade and will crumble if the 
constitutional right to abortion is abolished. What might happen to this case otherwise is less 
clear. Most experts, including Dr. Prine and Susan Yanow, are not worried about the FDA 
forcing Aid Access to shut down. They see it as unlikely in the first place, characterizing it as 
harassment rather than a legitimate case, and say that even if the FDA succeeds, online 
prescription of mifepristone and misoprostol will continue one way or another. Aid Access is just 
one source among a large and growing selection. According to a 2018 fact sheet published by the 
Charlotte Lozier Institute, at least 72 websites sell one or both abortion pills at an average price 
of $167 for one kit (and less per kit in bundles). While some (30) are focused on abortion pills, 
others (42) sell them among a wide variety of drugs. Though most of these sites only prescribe 
the drugs through the 10th week of pregnancy, 20 have no gestational limit.262 Thus, the role of 
information networks is crucial to ensuring safe use. 
Because effective regulatory oversight and enforcement of online pharmacies is an 
impossible task for the FDA, the agency will not be able to shut down the practice of self-
sourcing abortion pills via the internet. If it succeeds in forcing Aid Access to stop providing to 
US patients, women will simply turn to other, lower quality websites that care less about patient 
safety. In doing so, they are putting themselves at risk of prosecution, though this threat is now 
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nearly negligible and is much less intimidating than the potential complications of unsafe 
abortion. If the FDA suddenly decided to crack down on self-managed MA—using effort they 
might otherwise be directing to the opioid epidemic, teen vaping or cocaine import—the legal 
risks could absolutely become something to worry about. Until then, or until the legal landscape 
surrounding the medications is seriously reformed, the practice will continue more or less as is. 
What then of the confrontation between subversive and institutionalized power at play? It is 
true that self-managed MA threatens the regulatory authority of the FDA as well as the state-
based and medical control of abortion. It is also true that the futility of stopping the practice 
means it will continue to grow in popularity, augmenting its subversive power. Though an 
enlightening approach, our actors do not operate with nearly enough simplicity outside the realm 
of theory to boil it down to one epic showdown. It’s not a battle between women and doctors for 
who gets to control abortion as the “provider”—as the true goal of the self-managed movement 
is to add to the spectrum of abortion services available, not to overtake it. Furthermore, 
institutionalized power doesn’t have to respond. The FDA may very well engage in a game of 
whack-a-mole with online pharmacies, but it is unlikely they will suddenly begin enforcing 
against the importation of drugs for personal use, or that abortion pills would be the priority in 
that scenario. Unless future administrations can undo Trump’s impact on the courts, unless state 
legislatures decide to embrace the priorities of public health and women’s rights, it is most likely 
that self-managed MA will continue underground for quite some time. Thus, community-based 
efforts to spread information about the pills, in conjunction with fundraising to help women 
cover the online pharmacy costs, will be crucial to maximizing the technology’s potential in 
immediate circumstances. 
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Conclusion 
 
 “A big part of people’s resistance to self-managed abortion stems from their 
uninterrogated allegiance to the medical model of care, and to believing that we are not 
capable of knowing our bodies and caring for bodies, and that we must rely on people in 
white coats to tell us what to do.”263  
—Jill Adams 
For as long as the medical profession has existed in the US, unbalanced power dynamics 
have stood between women with reproductive health rights and actors who feel justified in 
constraining their ability to make autonomous decisions. Abortion restrictions, under the guise of 
public health and safety, have served to preserve these power dynamics and maintain a gap 
between “choice” and “access,” one which may either materialize as a wide abyss or hardly 
register as a crack depending on one’s social and economic resources. This assemblage was 
served by the conventional alignment of “safe” abortion with “legal” and has been undermined 
by the divorce necessitated by MA’s development. 
 Self-managed MA invites questioning the status quo. As Jill Adams suggests above, we 
are conditioned to put blind faith in the medical model of care, to trust its expert authority on 
what our own bodies need. It follows that we become dependent on the medical institution 
without even realizing it. The Jane collective’s demedicalization campaign was so radical 
because it simultaneously woke women up to their reliance and released them from it. History is 
now repeating itself, as more women learn about abortion pills and gain experiential expertise 
from using them. Jamilla Perritt, an OB-GYN, explains, “This is a really unique opportunity to 
say, ‘What are the things that we’re doing that are not grounded in medical evidence, that are 
actually limiting access to care?’ It may be that we have an opportunity to demedicalize the way 
abortion care is provided in this country.”264 Self-managed MA has challenged the authority of 
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institutional power, and its safety, ease and efficacy have subverted medical hierarchies long 
taken for granted.  
 Not only is the practice disruptive, but so too is the technology it employs. Despite the 
uphill task of implementation and burdensome barriers to access, MA has transformed the way 
abortion care is provided in the US and around the world. It will never fully replace vacuum and 
D&E methods, but it already accounts for nearly 40% of all clinic-based abortions and is well on 
its way to becoming the norm for early pregnancy termination.265 In conjunction with 
telemedicine, MA could facilitate provision of abortion care in the most underserved areas, and 
doctors and scientists are currently working on a research agenda for moving the pills OTC.266 
MA has thus enabled entirely new capacities with enormous promise for meaningfully expanding 
access, and certain characteristics of the technology itself increase its disruptive potential. The 
physical form of the pills, for example, makes them easy to ship and transport, and their gradual 
effects also afford a layer of mobility to the user. Additionally, the mechanism’s similarity to that 
of miscarriage makes it easier to disguise and more likely to feel like a natural process. MA, 
then, has also subverted traditional assumptions about the experience of abortion. 
 The disruptive qualities of self-managed MA are exactly what make it powerful as a tool 
for achieving reproductive justice. Telemedicine and OTC abortion’s ability to narrow the gap 
between choice and access could restore meaning to the legal right to abortion for the young, 
rural, undocumented and low-income women, disproportionately of color, who are most 
impacted by abortion restrictions. Cultural ignorance and discrimination by providers lead many 
marginalized women to distrust the medical system, and those women may feel safer when self-
managing. Furthermore, the safe, effective and low-tech nature of abortion pills lends itself to 
self-empowerment. Susan Yanow and Kinga Jelinska elaborate: 
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“Supporting the use of pills on one’s own and putting the tools for safe abortion directly in 
the hands of those who want and need them is an empowerment strategy. This is a 
challenge to the prevailing narrative that stigmatizes abortion and frames it as safe only 
when supervised by a trained medical professional. By claiming this knowledge for 
ourselves, self-managed abortion is an expression of the fundamental feminist principle 
and basic human right to bodily autonomy, and to our right to control our own health care: 
core tenets of reproductive justice.”267 
 
Information-sharing and support networks surround the practice; DIY becomes “do it together,” 
and empowerment extends to each party and wherever they take it next. In this way, community-
level efforts destigmatize abortion and build collective power.  
 Widespread access to self-managed MA would quickly reduce complications from unsafe 
abortion, mitigate the consequences of inequitable barriers to access and facilitate women’s 
realization of their human right to reproductive justice. Over the years, as allegiance to the 
medical model of abortion wanes, power could gradually shift from state and medical institutions 
to women and their support networks—those most affected by abortion. Moving forward, the 
goals are clear, but the road is congested.  
 The full potential of MA is trapped in the same political playground that first tried to 
swallow it decades ago. In 1990, Cory Richards and Rachel Benson Gold wrote: 
“The FDA must stop playing politics with RU 486. If this drug is ever to be brought to the 
U.S. market, the agency will need to convince American women and, even more important, 
the pharmaceutical industry that it will evaluate RU 486 on the basis of safety and efficacy 
only. The current politically motivated ban on importing RU 486 for personal use under a 
physician's supervision must be rescinded… The medical and scientific communities are 
uniquely positioned to help bring about these needed policy changes… They should be 
motivated not only by concern for the well-being of virtually all Americans, but by the 
need to preserve scientific integrity.”268 
 
The struggle has certainly evolved over the years. Prominent medical organizations and scientific 
communities have now taken their place in the social debate, on the side of evidence and against 
the REMS. They have also identified several research gaps, pertaining to women’s preferences 
and experiences with self-use of MA, the distribution and provision of MA information and 
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drugs, and clinical outcomes following self-use.269 Filling these gaps will require rigorous 
research and collaborative work, and as we know, science embroiled in the politicized abortion 
debate is held to wildly different standards by different actors; one sees consensus where the 
other sees deception. All evidence suggests we will one day see mifepristone and misoprostol 
beside Tylenol and Viagra in pharmacies, and before that it will be available through 
telemedicine—but still too late for many. 
 The suppression of MA’s potential in the meantime will have serious consequences. Due 
to COVID-19, we are currently seeing the worst of them play out at an unprecedented velocity.  
Anti-abortion politicians have attempted to use the pandemic as an excuse to ban abortion 
altogether by falsely categorizing it as “nonessential.” To affirm the necessity of abortion, 
ACOG released a statement in collaboration with other leading OB-GYN organizations, 
declaring it “a time-sensitive service for which a delay of several weeks, or in some cases days, 
may increase the risks or potentially make it completely inaccessible.”270 While many of the bans 
have been struck down, others have successfully imposed additional barriers to access. “The 
consequences of being unable to obtain an abortion,” ACOG states, “profoundly impact a 
person’s life, health, and well-being.”271 Stay-at-home orders and additional childcare 
responsibilities already make clinic-based care harder to access, and while evidence would 
support abortion’s inclusion in the broad shift to telemedicine, state laws and the REMS prohibit 
this from happening. The FDA could, at least temporarily, change the REMS classification to 
allow telemedicine abortion, yet it has not and shows no signs of doing so.  
Meanwhile, the international supply chain of online pharmacies has been disrupted due to 
halts on trade. Essentially, self-managed MA has become incredibly difficult to access in the 
moment it’s needed most. “Our leaders should be working to support the nation’s full network of 
 Matthews 94 
safety-net health care providers during these uncertain times. Instead, the Senate bill targets 
Planned Parenthood and expands the harmful and discriminatory Hyde amendment, putting up 
even more barriers to care for women, people with low incomes, and communities of color,”272 
said Alexis McGill Johnson, acting president of Planned Parenthood Action Fund. In her own 
statement, Kelsey Ryland, director of federal strategies for the reproductive justice group All* 
Above All, adds, “Our communities across the country are doing everything we can to keep 
ourselves and our families safe, and our elected officials should be doing the same—not blocking 
health care for communities that already face significant barriers. Once again we’re seeing how 
far Trump and anti-abortion politicians will go to push their political agenda.”273 That is, they are 
exploiting a global emergency to consolidate institutional power at the expense of personal rights 
and liberties. 
Activists prepared for a post-Roe world, but they couldn’t have anticipated a pandemic, 
let alone ensure unofficial supplies of the pills throughout its duration. With fewer feasible routes 
to safe abortion than ever, more people may return to unsafe self-induced methods in the coming 
weeks, months or however long it takes to return to “normal.” But the crisis has also presented 
an opportunity to reflect on what “normal” even meant —as George Packer wrote in The 
Atlantic, “The coronavirus didn’t break America. It revealed what was already broken.”274 In 
many ways, “normal” still meant accessing care despite systems built to maintain the axes of 
subordination preserving institutionalized power; it still meant political gain over public health 
and equitable care. For reproductive autonomy and justice, going back to “normal” is not an 
option. As talk of the UK legalizing at-home MA circulates, as demand for telemedicine abortion 
in the US escalates, the crisis may bring to light what’s been held hostage for decades: the little 
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pills that could. If unleashed, the full potential of MA could transform the landscape of access 
and power into one more conducive to achieving reproductive justice.   
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